data_6q5z_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6q5z _Structure_validation_residue.Date_analyzed 2019-04-12 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 21.6 t . . . . . 0 N--CA 1.457 -0.113 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.02 -39.56 94.42 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -178.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.19 -39.72 71.86 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.62 157.78 40.9 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-O 121.063 0.458 . . . . 0.0 112.07 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -83.35 122.0 3.14 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 N-CA-C 108.262 -1.476 . . . . 0.0 108.262 175.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 19.7 t -149.71 111.59 4.57 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -59.99 -40.05 87.82 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -178.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -156.68 133.25 10.08 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.954 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 148.39 -168.9 29.05 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 78.3 m -102.65 127.71 49.64 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.861 -0.335 . . . . 0.0 110.142 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 50.8 t -104.15 114.1 28.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.049 0.452 . . . . 0.0 110.894 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -138.9 146.83 41.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.274 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 49.63 41.37 21.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.751 0.31 . . . . 0.0 110.685 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 55.92 35.82 26.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.005 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 32.4 tpt180 -146.7 131.98 18.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.121 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 43.6 t -95.31 121.52 37.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.011 0.434 . . . . 0.0 110.716 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 58.6 ttm-85 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.596 -179.966 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.1 t . . . . . 0 N--CA 1.455 -0.22 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.08 -40.31 95.44 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.699 -178.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.4 -39.89 69.42 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 120.93 -0.652 . . . . 0.0 111.474 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -152.42 156.88 33.76 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.563 0.22 . . . . 0.0 111.526 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -82.83 122.32 3.42 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 N-CA-C 107.882 -1.622 . . . . 0.0 107.882 175.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 18.0 t -141.89 116.01 9.39 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.977 -178.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 58.2 mtmt -61.6 -40.06 93.46 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.689 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -160.32 130.65 5.39 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.829 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 152.26 -172.2 31.5 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 69.1 m -99.39 129.01 45.55 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.7 t -104.16 110.51 22.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.123 0.487 . . . . 0.0 110.853 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -138.65 149.4 45.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.729 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 51.23 39.91 24.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.936 0.398 . . . . 0.0 110.324 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 56.72 30.02 16.85 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.299 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -139.09 144.95 38.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.078 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 47.6 t -105.38 121.21 43.43 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.635 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.837 -179.853 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 16.5 t . . . . . 0 C--O 1.232 0.147 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.1 -40.48 93.64 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 120.808 -0.71 . . . . 0.0 111.59 -178.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.3 -41.28 68.76 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 120.454 -0.879 . . . . 0.0 111.417 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -149.1 159.42 37.21 Favored Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -84.23 122.26 2.84 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 N-CA-C 108.026 -1.567 . . . . 0.0 108.026 175.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 22.7 t -143.4 117.41 9.43 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.805 -178.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -60.29 -45.23 94.08 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.419 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -159.45 130.24 5.9 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.079 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 156.12 -166.94 33.23 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 83.2 m -102.02 127.13 49.03 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 47.2 t -102.86 110.45 22.38 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.693 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -138.61 148.87 44.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.0 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 50.09 40.98 22.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.92 0.39 . . . . 0.0 110.482 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 54.69 33.07 18.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.892 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 78.3 ttt-85 -143.0 134.08 25.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.962 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 45.5 t -97.34 120.79 38.35 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.803 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.45 179.919 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 12.8 t . . . . . 0 C--O 1.231 0.1 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.04 -40.63 95.79 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 121.05 -0.595 . . . . 0.0 111.814 -178.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.04 -39.73 73.47 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.41 156.15 36.82 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.852 0.358 . . . . 0.0 111.346 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -83.69 122.28 3.06 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 N-CA-C 108.126 -1.529 . . . . 0.0 108.126 175.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 21.0 t -144.25 110.97 5.66 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 120.311 -0.556 . . . . 0.0 110.299 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -60.07 -40.34 89.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.95 -178.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 93.6 t80 -154.28 130.9 10.68 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.101 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 149.41 -171.0 29.62 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 79.5 m -101.66 130.46 48.02 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 49.9 t -104.8 111.58 24.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.099 0.476 . . . . 0.0 111.093 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -138.37 148.27 44.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.087 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 50.42 40.67 23.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.854 0.359 . . . . 0.0 110.48 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 56.76 30.67 18.08 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.171 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -139.47 147.07 40.83 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 42.6 t -108.47 124.08 49.87 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.445 -0.502 . . . . 0.0 111.09 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.582 179.872 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 10.5 t . . . . . 0 N--CA 1.456 -0.132 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.05 -39.41 94.28 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.618 -178.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.26 -39.73 71.09 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.93 152.44 31.7 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 120.724 0.297 . . . . 0.0 111.471 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -81.04 122.19 4.19 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 N-CA-C 107.692 -1.695 . . . . 0.0 107.692 175.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 18.4 t -142.75 111.27 6.21 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.623 -177.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -57.36 -45.63 84.18 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.642 -178.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 93.6 t80 -152.86 130.37 11.44 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.822 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 154.48 -171.44 32.95 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.7 m -102.48 126.73 49.62 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 50.5 t -104.03 118.21 36.12 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.995 -179.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -152.92 144.67 23.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.643 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 57.07 37.57 28.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.855 0.36 . . . . 0.0 110.299 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 57.85 29.67 17.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.468 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -137.56 149.44 46.71 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 52.1 t -117.22 126.11 52.23 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.132 0.491 . . . . 0.0 110.844 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.431 -179.968 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.9 t . . . . . 0 N--CA 1.454 -0.275 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.51 -41.65 95.54 Favored Glycine 0 CA--C 1.523 0.535 0 C-N-CA 120.347 -0.93 . . . . 0.0 111.299 -178.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.57 -41.63 65.1 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 120.766 -0.73 . . . . 0.0 111.968 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -152.37 158.71 33.41 Favored Pre-proline 0 N--CA 1.464 0.226 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -178.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -81.81 122.65 3.96 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 N-CA-C 106.815 -2.033 . . . . 0.0 106.815 174.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 26.0 t -135.33 121.03 19.53 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 119.748 -0.781 . . . . 0.0 112.216 -177.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -59.43 -41.45 89.62 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.838 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 93.5 t80 -173.04 131.17 0.49 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.718 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 157.93 -166.01 33.85 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 71.8 m -99.62 127.75 45.72 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 48.9 t -104.05 110.19 22.26 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.454 -0.499 . . . . 0.0 110.667 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -139.32 151.35 46.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.799 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 51.84 39.16 25.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.886 0.374 . . . . 0.0 110.368 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 57.37 29.22 16.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.09 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -139.19 148.05 42.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.357 -0.383 . . . . 0.0 109.97 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 52.3 t -111.8 125.6 54.18 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.205 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.433 179.391 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.8 t . . . . . 0 N--CA 1.456 -0.174 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.46 -40.4 96.12 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.669 -178.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.46 -40.03 68.64 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.319 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.94 154.67 34.65 Favored Pre-proline 0 C--N 1.329 -0.303 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -179.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -81.42 122.39 4.07 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 N-CA-C 107.955 -1.594 . . . . 0.0 107.955 175.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 18.1 t -143.2 111.97 6.47 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.313 -178.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -58.0 -45.84 86.19 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.491 -178.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -153.05 129.83 10.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.816 0.341 . . . . 0.0 110.718 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 154.08 -172.68 32.72 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.7 m -100.31 128.2 46.43 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 49.9 t -103.33 111.49 23.93 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.967 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -139.54 147.64 41.5 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.12 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 49.8 43.28 24.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.893 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 53.52 34.92 19.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.792 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -145.17 134.1 22.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.868 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 45.9 t -99.08 123.86 43.68 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.193 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.744 179.452 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 16.2 t . . . . . 0 N--CA 1.456 -0.164 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.46 -39.37 94.8 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.24 -40.05 71.07 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.11 157.12 46.62 Favored Pre-proline 0 C--N 1.331 -0.223 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -179.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -83.26 122.26 3.23 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 N-CA-C 108.215 -1.494 . . . . 0.0 108.215 176.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 24.1 t -151.36 110.99 4.01 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 120.589 -0.445 . . . . 0.0 110.159 -178.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -60.67 -40.45 92.16 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 111.779 0.288 . . . . 0.0 111.779 -179.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 94.7 t80 -154.02 134.19 13.28 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.058 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 147.49 -170.58 28.24 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 86.5 m -102.05 129.31 48.33 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 47.1 t -103.82 111.7 24.34 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.026 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -140.75 148.7 41.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.582 179.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 50.94 40.56 25.47 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.927 0.394 . . . . 0.0 110.862 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 58.68 25.04 12.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.063 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 91.8 mtm180 -138.64 144.81 39.86 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.218 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 45.7 t -103.39 123.19 46.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.955 0.407 . . . . 0.0 111.126 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 65.2 ttt180 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.143 179.626 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 48.8 t . . . . . 0 C--O 1.23 0.068 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.23 -40.98 94.61 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.21 -177.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.38 -41.39 67.69 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 120.47 -0.871 . . . . 0.0 111.652 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -152.72 163.01 24.88 Favored Pre-proline 0 CA--C 1.515 -0.369 0 CA-C-O 120.956 0.408 . . . . 0.0 111.696 -179.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -84.24 122.24 2.83 Favored 'Trans proline' 0 C--N 1.301 -1.928 0 C-N-CA 121.326 1.351 . . . . 0.0 109.191 176.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -133.5 111.32 10.61 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.98 -179.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -57.89 -40.88 81.36 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.34 -178.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 93.4 t80 -148.08 119.4 7.83 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.741 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 168.78 -170.5 42.38 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.429 -1.069 . . . . 0.0 110.429 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.9 m -105.5 127.73 53.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.972 0.415 . . . . 0.0 110.903 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 44.7 t -104.75 114.52 28.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.989 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.2 tpt180 -146.74 137.35 23.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.325 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 51.75 41.81 29.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.637 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 57.48 39.25 28.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.239 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -139.14 144.33 38.6 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.512 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 17.2 t -108.05 124.88 50.86 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.887 0.375 . . . . 0.0 110.615 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.633 -179.883 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 31.3 t . . . . . 0 N--CA 1.454 -0.227 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.92 -40.73 95.68 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -179.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.49 -40.43 67.92 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 121.011 -0.614 . . . . 0.0 111.696 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.7 152.99 60.96 Favored Pre-proline 0 N--CA 1.464 0.267 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -179.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -81.84 122.54 3.92 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 N-CA-C 108.004 -1.575 . . . . 0.0 108.004 175.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 44.5 t -146.69 130.32 16.93 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.57 -177.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 58.4 mtmt -63.23 -42.24 99.21 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.233 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -173.25 134.29 0.53 Allowed 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.937 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 156.73 -166.26 33.32 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.939 -0.865 . . . . 0.0 110.939 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 78.9 m -94.8 130.61 41.29 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 41.9 t -106.21 116.33 31.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.008 0.432 . . . . 0.0 110.828 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.1 tpt180 -145.46 139.36 26.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.324 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 52.86 43.85 31.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.279 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 56.79 33.02 22.33 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.304 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -138.41 147.54 43.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.003 179.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 43.2 t -119.37 127.45 53.16 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.995 0.426 . . . . 0.0 111.098 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 69.0 ttt180 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.178 179.537 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 21.4 t . . . . . 0 N--CA 1.453 -0.283 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.56 -41.65 95.64 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.373 -0.918 . . . . 0.0 111.064 -178.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.66 -41.46 64.57 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.976 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -152.39 159.42 32.71 Favored Pre-proline 0 N--CA 1.464 0.233 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -178.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -82.0 122.5 3.83 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 N-CA-C 107.071 -1.934 . . . . 0.0 107.071 174.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 24.8 t -135.06 121.42 20.35 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 119.82 -0.752 . . . . 0.0 112.087 -177.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -59.68 -41.88 91.68 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.85 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -172.67 131.4 0.55 Allowed 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.943 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 156.68 -166.67 33.43 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 84.6 m -99.24 128.66 45.39 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 44.1 t -104.67 109.76 21.82 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.624 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -139.18 150.69 45.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.153 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 51.09 40.39 25.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.966 0.412 . . . . 0.0 110.376 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 55.06 36.11 26.21 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.713 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 43.8 ttm180 -147.14 134.41 20.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.146 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 53.1 t -100.45 123.0 44.09 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.397 -0.521 . . . . 0.0 111.029 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 . . . . . 0 C--N 1.331 -0.21 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.27 179.647 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 22.2 t . . . . . 0 N--CA 1.452 -0.344 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.56 -41.19 95.4 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 120.178 -1.01 . . . . 0.0 110.993 -178.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.64 -42.78 62.0 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.042 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -152.56 159.61 32.33 Favored Pre-proline 0 N--CA 1.463 0.211 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -178.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -81.77 122.73 3.99 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 N-CA-C 106.805 -2.036 . . . . 0.0 106.805 174.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 29.8 t -136.68 124.03 21.98 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 119.878 -0.729 . . . . 0.0 111.68 -176.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -58.27 -47.64 82.95 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.6 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -170.23 131.92 1.01 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.691 179.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 158.97 -164.69 33.87 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 69.8 m -97.84 127.85 44.07 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 49.3 t -104.96 108.01 19.29 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.467 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -140.73 153.1 45.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.181 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 52.13 39.38 26.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.879 0.371 . . . . 0.0 110.584 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 57.99 25.34 12.13 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.667 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 92.1 mtm180 -139.56 147.14 40.77 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 47.8 t -106.82 125.57 51.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.041 0.448 . . . . 0.0 111.036 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.408 179.792 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.0 t . . . . . 0 N--CA 1.454 -0.241 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.43 -40.96 94.98 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.844 -0.903 . . . . 0.0 110.844 -178.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.45 -41.7 66.22 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.919 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -152.54 158.01 33.42 Favored Pre-proline 0 N--CA 1.465 0.305 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -178.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -81.53 122.64 4.09 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 N-CA-C 106.944 -1.983 . . . . 0.0 106.944 174.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 23.5 t -136.15 120.66 18.18 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 119.901 -0.719 . . . . 0.0 112.268 -176.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -57.72 -47.24 82.97 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.481 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 94.5 t80 -168.76 129.89 1.22 Allowed 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.825 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 157.73 -168.22 34.32 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 77.5 m -96.59 129.53 43.96 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 47.2 t -103.58 115.45 30.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.906 0.384 . . . . 0.0 110.611 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 19.4 tpt180 -155.81 150.52 26.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.945 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 57.4 37.66 28.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.064 0.459 . . . . 0.0 110.446 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 56.71 26.25 11.09 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.211 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -139.78 150.23 44.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.314 -0.403 . . . . 0.0 109.927 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 53.9 t -118.5 126.66 52.49 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.853 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 58.4 ttm-85 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.45 179.866 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 52.5 t . . . . . 0 N--CA 1.455 -0.21 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.65 -40.56 92.81 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 120.621 -0.8 . . . . 0.0 111.549 -178.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.49 -43.88 60.03 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 120.43 -0.89 . . . . 0.0 111.527 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -152.76 165.03 18.46 Favored Pre-proline 0 N--CA 1.466 0.341 0 CA-C-O 121.025 0.44 . . . . 0.0 111.862 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -83.38 122.38 3.2 Favored 'Trans proline' 0 C--N 1.302 -1.901 0 C-N-CA 121.554 1.503 . . . . 0.0 108.974 176.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 8.8 t -115.78 113.08 22.95 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.185 -178.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -53.5 -50.01 66.3 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 119.681 -0.807 . . . . 0.0 110.157 -179.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 93.4 t80 -170.94 100.48 0.22 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.313 -0.403 . . . . 0.0 109.926 178.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -178.57 -161.34 26.24 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 64.7 m -101.13 133.96 44.87 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 50.0 t -102.12 111.29 23.52 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.575 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -138.99 146.93 41.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.343 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 47.32 43.98 15.66 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.154 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 50.9 t0 54.51 41.58 31.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.953 0.406 . . . . 0.0 110.289 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 78.1 ttt-85 -145.27 133.35 21.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.879 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -93.74 111.83 23.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.274 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 . . . . . 0 C--N 1.332 -0.18 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.142 -179.501 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 12.8 t . . . . . 0 N--CA 1.456 -0.142 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.64 -39.39 93.34 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.51 -0.636 . . . . 0.0 111.51 -178.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.23 -39.67 71.44 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.86 155.62 33.84 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.817 0.341 . . . . 0.0 111.421 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -82.77 122.37 3.45 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 N-CA-C 107.895 -1.617 . . . . 0.0 107.895 175.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 19.7 t -143.46 112.42 6.63 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.544 -178.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -57.75 -44.9 86.42 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.54 -178.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -153.3 132.81 12.93 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.908 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 150.97 -169.93 30.71 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 78.3 m -102.36 130.13 49.01 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.7 t -105.45 111.79 24.64 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.426 -0.509 . . . . 0.0 111.178 -179.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -140.13 149.02 42.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.821 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 51.48 38.55 22.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.962 0.411 . . . . 0.0 110.335 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 57.5 30.43 18.68 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.221 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 86.0 mtp180 -138.46 147.31 43.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.242 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 42.9 t -106.7 123.1 47.63 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.201 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 66.1 ttt180 . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.309 179.767 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.7 t . . . . . 0 N--CA 1.451 -0.421 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.94 -40.57 93.42 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 120.112 -1.042 . . . . 0.0 110.537 -178.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.59 -41.4 65.41 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.119 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -152.16 160.59 31.19 Favored Pre-proline 0 N--CA 1.466 0.337 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -178.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -82.42 122.64 3.67 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 N-CA-C 106.802 -2.038 . . . . 0.0 106.802 174.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 33.2 t -136.99 125.25 23.19 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 119.796 -0.762 . . . . 0.0 111.946 -176.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -59.11 -46.82 87.32 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.39 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -173.03 132.89 0.52 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.605 179.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 156.79 -164.39 32.65 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 84.6 m -98.54 129.94 45.1 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.1 t -106.07 109.51 21.48 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.732 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 68.1 mtp85 -140.66 153.1 45.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.093 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 52.38 38.75 25.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.987 0.422 . . . . 0.0 110.667 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 58.12 25.42 12.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.588 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 91.5 mtm180 -139.56 145.82 39.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.166 178.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 51.4 t -107.29 125.04 50.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.97 0.415 . . . . 0.0 111.118 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 58.3 ttm-85 . . . . . 0 C--N 1.331 -0.223 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.389 179.785 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 16.4 t . . . . . 0 N--CA 1.452 -0.345 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.5 -41.59 95.49 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 120.424 -0.893 . . . . 0.0 111.311 -178.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.64 -41.64 64.43 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.844 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -152.47 160.57 31.06 Favored Pre-proline 0 CA--C 1.519 -0.22 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.054 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -82.71 122.38 3.48 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 N-CA-C 107.139 -1.908 . . . . 0.0 107.139 174.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 21.1 t -139.17 122.08 16.63 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 119.596 -0.842 . . . . 0.0 112.015 -177.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -57.31 -47.3 81.86 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.743 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -168.1 128.51 1.33 Allowed 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.551 179.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 165.07 -168.37 39.18 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.6 t -95.69 117.28 30.2 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 48.9 t -98.43 107.68 20.2 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.206 -0.598 . . . . 0.0 110.677 -179.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 85.5 mtp180 -140.56 152.99 45.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.954 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 52.39 38.21 24.6 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.91 0.386 . . . . 0.0 110.469 179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 58.31 26.67 14.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.661 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 91.2 mtm180 -139.99 146.24 38.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.514 179.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 54.1 t -101.52 120.71 40.73 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.559 -0.457 . . . . 0.0 110.662 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.231 -179.563 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 20.7 t . . . . . 0 N--CA 1.455 -0.209 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.62 -39.69 93.7 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 -179.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.44 -40.03 68.91 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.558 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -151.79 160.4 31.68 Favored Pre-proline 0 N--CA 1.464 0.273 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -179.169 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -84.3 123.02 2.94 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 106.798 -2.039 . . . . 0.0 106.798 174.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 13.7 t -133.69 124.57 26.94 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 119.503 -0.879 . . . . 0.0 111.369 -176.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -57.1 -50.88 71.41 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 119.633 -0.827 . . . . 0.0 109.685 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -168.77 131.49 1.35 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.286 179.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 157.72 -165.47 33.56 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 79.5 m -99.71 128.82 45.8 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 54.1 t -104.35 110.42 22.65 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.836 -0.345 . . . . 0.0 111.442 -179.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -142.48 152.39 42.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.308 179.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 50.01 42.66 24.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.545 179.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 47.8 t0 56.64 28.42 14.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.945 0.403 . . . . 0.0 111.198 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 91.9 mtm180 -140.54 146.88 38.67 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 54.0 t -120.39 124.42 45.47 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.674 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 58.0 ttm-85 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.172 179.804 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 13.1 t . . . . . 0 N--CA 1.45 -0.436 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.85 -41.89 96.33 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 120.437 -0.887 . . . . 0.0 111.363 -178.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.51 -42.51 63.72 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 120.858 -0.686 . . . . 0.0 111.952 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -152.63 161.71 28.46 Favored Pre-proline 0 N--CA 1.463 0.194 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -178.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -84.3 122.66 2.88 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.0 1.8 . . . . 0.0 108.387 175.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -128.73 120.9 27.3 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.373 0.606 . . . . 0.0 111.726 -178.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -59.14 -41.47 88.37 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.153 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -172.85 125.53 0.46 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.851 178.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 163.75 -166.83 37.58 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.834 -0.907 . . . . 0.0 110.834 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 85.8 m -101.97 131.8 48.16 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.8 t -117.08 120.96 39.96 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.705 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -141.94 139.42 32.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.127 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 54.33 46.15 25.72 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.028 -179.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 55.6 34.25 22.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.592 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 61.8 ttp180 -141.96 129.34 21.2 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 46.3 t -101.5 121.54 42.15 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.188 -179.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 58.7 ttm-85 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.367 179.937 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 21.6 t . . . . . 0 N--CA 1.452 -0.353 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.94 -40.41 93.2 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 120.048 -1.073 . . . . 0.0 110.879 -178.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.59 -40.93 66.37 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 120.851 -0.69 . . . . 0.0 111.715 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -152.13 159.42 32.92 Favored Pre-proline 0 N--CA 1.465 0.279 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -178.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -82.43 122.49 3.63 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 N-CA-C 106.94 -1.985 . . . . 0.0 106.94 174.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 27.1 t -136.32 122.24 20.05 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 119.793 -0.763 . . . . 0.0 112.13 -177.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -59.98 -41.78 92.76 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.57 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -173.86 133.22 0.44 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.788 0.328 . . . . 0.0 110.7 179.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 155.34 -165.75 32.46 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 70.7 m -98.89 128.67 45.14 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 44.8 t -102.91 108.65 19.93 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.625 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -139.94 151.08 45.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.972 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 50.64 40.91 25.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.751 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 55.19 33.61 20.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.807 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 44.4 ttm180 -146.87 135.2 21.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.071 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 53.2 t -99.32 121.91 41.74 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.279 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 . . . . . 0 C--N 1.332 -0.191 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.599 179.656 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.399 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.27 142.81 58.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.876 0.37 . . . . 0.0 110.928 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 79.0 mtm -63.0 -39.69 95.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.628 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.06 16.61 80.57 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.457 -0.657 . . . . 0.0 111.457 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 51.0 p-10 -83.49 176.77 8.81 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.047 0.451 . . . . 0.0 110.95 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.9 p -139.82 159.04 27.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.686 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -137.44 147.26 45.21 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 21.6 t -108.15 141.59 39.64 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.02 -39.56 94.42 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -178.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.19 -39.72 71.86 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.62 157.78 40.9 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-O 121.063 0.458 . . . . 0.0 112.07 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -83.35 122.0 3.14 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 N-CA-C 108.262 -1.476 . . . . 0.0 108.262 175.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 19.7 t -149.71 111.59 4.57 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -59.99 -40.05 87.82 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -178.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -156.68 133.25 10.08 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.954 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 148.39 -168.9 29.05 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 78.3 m -102.65 127.71 49.64 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.861 -0.335 . . . . 0.0 110.142 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 50.8 t -104.15 114.1 28.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.049 0.452 . . . . 0.0 110.894 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -138.9 146.83 41.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.274 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 49.63 41.37 21.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.751 0.31 . . . . 0.0 110.685 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 55.92 35.82 26.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.005 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 32.4 tpt180 -146.7 131.98 18.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.121 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 43.6 t -95.31 121.52 37.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.011 0.434 . . . . 0.0 110.716 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 58.6 ttm-85 -116.89 131.34 56.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.596 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -111.33 75.0 0.89 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 11.7 tt 169.64 149.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.555 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 55.44 37.97 29.63 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.296 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 41.9 t -148.68 131.53 16.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.877 0.37 . . . . 0.0 110.538 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 66.8 t0 . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 118.104 -0.951 . . . . 0.0 110.375 179.879 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.51 141.79 58.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.913 0.387 . . . . 0.0 110.572 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.3 mmt -130.19 149.8 51.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.624 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -77.02 170.66 55.16 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 47.5 p30 -157.24 176.14 13.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.899 0.381 . . . . 0.0 110.907 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.5 t -127.19 137.9 56.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.166 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -138.25 132.75 32.22 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.587 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.1 t -109.81 145.69 36.29 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.08 -40.31 95.44 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.699 -178.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.4 -39.89 69.42 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 120.93 -0.652 . . . . 0.0 111.474 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -152.42 156.88 33.76 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.563 0.22 . . . . 0.0 111.526 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -82.83 122.32 3.42 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 N-CA-C 107.882 -1.622 . . . . 0.0 107.882 175.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 18.0 t -141.89 116.01 9.39 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.977 -178.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 58.2 mtmt -61.6 -40.06 93.46 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.689 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -160.32 130.65 5.39 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.829 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 152.26 -172.2 31.5 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 69.1 m -99.39 129.01 45.55 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.7 t -104.16 110.51 22.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.123 0.487 . . . . 0.0 110.853 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -138.65 149.4 45.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.729 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 51.23 39.91 24.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.936 0.398 . . . . 0.0 110.324 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 56.72 30.02 16.85 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.299 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -139.09 144.95 38.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.078 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 47.6 t -105.38 121.21 43.43 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.635 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -109.84 133.04 53.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.837 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -122.86 74.7 1.22 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.0 tt 169.79 127.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 O-C-N 123.927 0.767 . . . . 0.0 110.498 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 50.72 38.88 20.54 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.914 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 43.4 t -61.49 -48.4 81.24 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.389 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.754 -179.889 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.25 152.51 37.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.822 0.344 . . . . 0.0 110.572 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 60.4 ttm -109.67 126.47 53.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.781 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -82.7 -179.67 52.8 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 51.6 p30 -155.95 175.78 13.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.951 0.405 . . . . 0.0 110.817 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 53.1 t -125.97 137.72 56.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.891 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -135.95 126.57 27.11 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.589 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 16.5 t -100.74 143.75 30.53 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.1 -40.48 93.64 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 120.808 -0.71 . . . . 0.0 111.59 -178.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.3 -41.28 68.76 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 120.454 -0.879 . . . . 0.0 111.417 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -149.1 159.42 37.21 Favored Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -84.23 122.26 2.84 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 N-CA-C 108.026 -1.567 . . . . 0.0 108.026 175.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 22.7 t -143.4 117.41 9.43 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.805 -178.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -60.29 -45.23 94.08 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.419 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -159.45 130.24 5.9 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.079 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 156.12 -166.94 33.23 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 83.2 m -102.02 127.13 49.03 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 47.2 t -102.86 110.45 22.38 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.693 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -138.61 148.87 44.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.0 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 50.09 40.98 22.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.92 0.39 . . . . 0.0 110.482 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 54.69 33.07 18.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.892 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 78.3 ttt-85 -143.0 134.08 25.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.962 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 45.5 t -97.34 120.79 38.35 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.803 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -109.1 134.56 51.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.45 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -119.42 74.99 1.03 Allowed 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.271 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.9 tt 171.42 142.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.422 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 52.77 37.51 24.08 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.7 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.5 t -145.97 130.72 18.02 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.517 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.546 179.972 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.388 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.94 -40.03 94.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.855 0.359 . . . . 0.0 110.694 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 79.0 mtm 53.97 40.66 31.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.57 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.47 177.95 53.97 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -108.57 137.7 46.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.803 0.335 . . . . 0.0 110.752 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 44.0 t -97.17 144.05 11.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.489 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -139.33 129.33 25.04 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 12.8 t -107.46 144.36 34.52 Favored 'General case' 0 C--O 1.231 0.1 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.04 -40.63 95.79 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 121.05 -0.595 . . . . 0.0 111.814 -178.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.04 -39.73 73.47 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.41 156.15 36.82 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.852 0.358 . . . . 0.0 111.346 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -83.69 122.28 3.06 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 N-CA-C 108.126 -1.529 . . . . 0.0 108.126 175.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 21.0 t -144.25 110.97 5.66 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 120.311 -0.556 . . . . 0.0 110.299 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -60.07 -40.34 89.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.95 -178.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 93.6 t80 -154.28 130.9 10.68 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.101 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 149.41 -171.0 29.62 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 79.5 m -101.66 130.46 48.02 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 49.9 t -104.8 111.58 24.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.099 0.476 . . . . 0.0 111.093 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -138.37 148.27 44.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.087 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 50.42 40.67 23.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.854 0.359 . . . . 0.0 110.48 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 56.76 30.67 18.08 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.171 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -139.47 147.07 40.83 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 42.6 t -108.47 124.08 49.87 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.445 -0.502 . . . . 0.0 111.09 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -121.44 136.4 54.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.582 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -121.31 75.0 1.14 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.66 -0.416 . . . . 0.0 109.999 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.3 tt 169.75 140.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.192 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 49.8 t0 51.63 41.98 29.27 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.233 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 53.7 t -99.57 119.41 38.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.795 0.331 . . . . 0.0 110.351 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 65.6 t0 . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.504 -179.82 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.381 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.51 153.96 36.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.864 0.364 . . . . 0.0 110.571 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 79.5 mtm -131.47 146.27 52.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.477 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -177.13 -178.32 46.74 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 52.8 p30 -155.56 177.72 11.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.74 0.305 . . . . 0.0 110.601 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 46.3 t -102.29 144.3 13.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.382 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -138.98 127.16 22.61 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 10.5 t -107.12 143.34 35.42 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.05 -39.41 94.28 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.618 -178.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.26 -39.73 71.09 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.93 152.44 31.7 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 120.724 0.297 . . . . 0.0 111.471 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -81.04 122.19 4.19 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 N-CA-C 107.692 -1.695 . . . . 0.0 107.692 175.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 18.4 t -142.75 111.27 6.21 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.623 -177.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -57.36 -45.63 84.18 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.642 -178.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 93.6 t80 -152.86 130.37 11.44 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.822 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 154.48 -171.44 32.95 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.7 m -102.48 126.73 49.62 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 50.5 t -104.03 118.21 36.12 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.995 -179.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -152.92 144.67 23.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.643 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 57.07 37.57 28.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.855 0.36 . . . . 0.0 110.299 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 57.85 29.67 17.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.468 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -137.56 149.44 46.71 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 52.1 t -117.22 126.11 52.23 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.132 0.491 . . . . 0.0 110.844 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -117.82 136.38 53.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.431 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -122.58 75.17 1.24 Allowed 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.04 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.0 tt 171.25 141.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.082 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 53.54 35.19 20.2 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.546 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 41.9 t -141.32 130.11 22.96 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.508 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 . . . . . 0 C--O 1.221 -0.447 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.749 -179.899 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.346 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.25 143.25 58.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.84 0.352 . . . . 0.0 110.588 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.9 ptp -153.91 161.35 42.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.575 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -177.55 179.54 48.16 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 51.3 p30 -155.61 177.04 11.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.798 0.332 . . . . 0.0 111.003 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.423 ' O ' ' O ' ' A' ' 13' ' ' CYS . 46.9 t -127.48 139.86 50.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -114.23 108.57 17.13 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.892 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.9 t -89.88 149.44 22.64 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.51 -41.65 95.54 Favored Glycine 0 CA--C 1.523 0.535 0 C-N-CA 120.347 -0.93 . . . . 0.0 111.299 -178.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.57 -41.63 65.1 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 120.766 -0.73 . . . . 0.0 111.968 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -152.37 158.71 33.41 Favored Pre-proline 0 N--CA 1.464 0.226 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -178.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -81.81 122.65 3.96 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 N-CA-C 106.815 -2.033 . . . . 0.0 106.815 174.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.423 ' O ' ' O ' ' A' ' 6' ' ' VAL . 26.0 t -135.33 121.03 19.53 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 119.748 -0.781 . . . . 0.0 112.216 -177.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -59.43 -41.45 89.62 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.838 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 93.5 t80 -173.04 131.17 0.49 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.718 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 157.93 -166.01 33.85 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 71.8 m -99.62 127.75 45.72 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 48.9 t -104.05 110.19 22.26 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.454 -0.499 . . . . 0.0 110.667 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -139.32 151.35 46.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.799 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 51.84 39.16 25.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.886 0.374 . . . . 0.0 110.368 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 57.37 29.22 16.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.09 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -139.19 148.05 42.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.357 -0.383 . . . . 0.0 109.97 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 52.3 t -111.8 125.6 54.18 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.205 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -117.13 131.52 56.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.433 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -122.77 75.25 1.26 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 11.5 tt 171.54 127.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.156 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 51.02 36.61 15.65 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.365 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 44.4 t -61.4 -47.8 84.15 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.324 -0.551 . . . . 0.0 110.632 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 117.961 -1.018 . . . . 0.0 110.538 179.876 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.26 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.83 142.0 58.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.859 0.362 . . . . 0.0 110.509 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 95.9 mmm -62.57 -39.64 94.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.465 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.69 -173.02 52.44 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 52.5 p30 -154.51 175.04 14.09 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.778 0.323 . . . . 0.0 110.701 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.7 t -102.8 146.1 11.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.194 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -139.05 126.81 22.05 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.8 t -105.04 145.87 29.88 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.46 -40.4 96.12 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.669 -178.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.46 -40.03 68.64 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.319 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.94 154.67 34.65 Favored Pre-proline 0 C--N 1.329 -0.303 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -179.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -81.42 122.39 4.07 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 N-CA-C 107.955 -1.594 . . . . 0.0 107.955 175.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 18.1 t -143.2 111.97 6.47 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.313 -178.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -58.0 -45.84 86.19 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.491 -178.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -153.05 129.83 10.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.816 0.341 . . . . 0.0 110.718 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 154.08 -172.68 32.72 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.7 m -100.31 128.2 46.43 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 49.9 t -103.33 111.49 23.93 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.967 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -139.54 147.64 41.5 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.12 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 49.8 43.28 24.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.893 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 53.52 34.92 19.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.792 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -145.17 134.1 22.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.868 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 45.9 t -99.08 123.86 43.68 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.193 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -105.74 140.66 38.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.744 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -122.25 117.68 26.72 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.3 tp 85.08 155.26 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 O-C-N 125.122 1.514 . . . . 0.0 109.89 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 51.5 t0 59.49 43.44 16.19 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -178.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 49.9 t -116.64 124.3 49.43 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.534 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 . . . . . 0 C--O 1.221 -0.435 0 CA-C-O 117.922 -1.037 . . . . 0.0 110.392 179.829 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.61 144.14 57.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.729 0.299 . . . . 0.0 110.466 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.4 ptt? -154.12 160.89 42.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.465 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -177.34 179.21 48.2 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 53.1 p30 -155.01 171.13 20.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.109 0.48 . . . . 0.0 110.996 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.1 p -138.91 159.56 30.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.324 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 52.2 p30 -139.7 157.31 45.97 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.437 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 16.2 t -117.69 140.44 49.66 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.46 -39.37 94.8 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.24 -40.05 71.07 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.11 157.12 46.62 Favored Pre-proline 0 C--N 1.331 -0.223 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -179.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -83.26 122.26 3.23 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 N-CA-C 108.215 -1.494 . . . . 0.0 108.215 176.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 24.1 t -151.36 110.99 4.01 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 120.589 -0.445 . . . . 0.0 110.159 -178.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -60.67 -40.45 92.16 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 111.779 0.288 . . . . 0.0 111.779 -179.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 94.7 t80 -154.02 134.19 13.28 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.058 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 147.49 -170.58 28.24 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 86.5 m -102.05 129.31 48.33 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 47.1 t -103.82 111.7 24.34 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.026 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -140.75 148.7 41.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.582 179.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 50.94 40.56 25.47 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.927 0.394 . . . . 0.0 110.862 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 58.68 25.04 12.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.063 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 91.8 mtm180 -138.64 144.81 39.86 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.218 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 45.7 t -103.39 123.19 46.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.955 0.407 . . . . 0.0 111.126 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 65.2 ttt180 -119.56 134.92 55.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.143 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -121.58 75.22 1.17 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.128 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 12.5 tt 171.47 139.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.796 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 53.2 t0 52.47 42.14 31.13 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.993 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 51.9 t -108.22 123.31 48.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.765 0.317 . . . . 0.0 110.527 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 67.1 t0 . . . . . 0 C--O 1.219 -0.539 0 CA-C-O 117.931 -1.033 . . . . 0.0 110.186 179.793 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.334 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.73 151.73 30.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.73 0.3 . . . . 0.0 110.389 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 64.1 mtt -131.5 150.32 52.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.742 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -72.61 159.4 53.63 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -70.48 140.69 51.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.879 0.371 . . . . 0.0 110.536 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 54.7 t -76.28 146.3 9.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.404 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -139.62 136.34 34.25 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.387 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 48.8 t -113.58 146.75 39.22 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.23 -40.98 94.61 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.21 -177.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.38 -41.39 67.69 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 120.47 -0.871 . . . . 0.0 111.652 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -152.72 163.01 24.88 Favored Pre-proline 0 CA--C 1.515 -0.369 0 CA-C-O 120.956 0.408 . . . . 0.0 111.696 -179.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -84.24 122.24 2.83 Favored 'Trans proline' 0 C--N 1.301 -1.928 0 C-N-CA 121.326 1.351 . . . . 0.0 109.191 176.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -133.5 111.32 10.61 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.98 -179.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -57.89 -40.88 81.36 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.34 -178.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 93.4 t80 -148.08 119.4 7.83 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.741 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 168.78 -170.5 42.38 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.429 -1.069 . . . . 0.0 110.429 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.9 m -105.5 127.73 53.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.972 0.415 . . . . 0.0 110.903 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 44.7 t -104.75 114.52 28.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.989 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.2 tpt180 -146.74 137.35 23.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.325 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 51.75 41.81 29.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.637 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 57.48 39.25 28.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.239 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -139.14 144.33 38.6 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.512 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 17.2 t -108.05 124.88 50.86 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.887 0.375 . . . . 0.0 110.615 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -115.2 134.45 55.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.633 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -118.21 74.93 0.98 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.33 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.0 tt 177.03 138.29 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.443 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 53.32 30.35 10.05 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.078 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 39.2 t -121.28 127.4 51.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.829 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 . . . . . 0 C--O 1.22 -0.471 0 CA-C-O 117.845 -1.074 . . . . 0.0 110.114 179.742 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.338 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.15 142.74 56.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.002 0.429 . . . . 0.0 110.764 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 60.5 ttm -69.68 130.26 41.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.324 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 81.7 5.16 90.07 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.161 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 45.1 p-10 -77.88 164.08 25.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 117.318 0.559 . . . . 0.0 110.596 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.4 p -158.52 124.44 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.403 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.187 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -86.99 138.8 31.2 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.696 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 31.3 t -91.98 143.23 26.69 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.258 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.92 -40.73 95.68 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -179.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.49 -40.43 67.92 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 121.011 -0.614 . . . . 0.0 111.696 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.7 152.99 60.96 Favored Pre-proline 0 N--CA 1.464 0.267 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -179.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -81.84 122.54 3.92 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 N-CA-C 108.004 -1.575 . . . . 0.0 108.004 175.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 44.5 t -146.69 130.32 16.93 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.57 -177.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 58.4 mtmt -63.23 -42.24 99.21 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.233 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -173.25 134.29 0.53 Allowed 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.937 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 156.73 -166.26 33.32 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.939 -0.865 . . . . 0.0 110.939 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 78.9 m -94.8 130.61 41.29 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 41.9 t -106.21 116.33 31.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.008 0.432 . . . . 0.0 110.828 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.1 tpt180 -145.46 139.36 26.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.324 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 52.86 43.85 31.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.279 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 56.79 33.02 22.33 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.304 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -138.41 147.54 43.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.003 179.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 43.2 t -119.37 127.45 53.16 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.995 0.426 . . . . 0.0 111.098 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 69.0 ttt180 -128.91 136.31 50.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.178 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -123.96 75.09 1.33 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.9 tt 169.01 132.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.721 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 56.14 27.07 10.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.322 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 45.8 t -61.84 -48.06 82.28 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.79 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 . . . . . 0 C--O 1.22 -0.5 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.646 -179.828 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.04 142.72 58.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.766 0.317 . . . . 0.0 110.574 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 28.0 ttt -111.71 127.55 55.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.709 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.12 177.65 54.25 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 52.4 p30 -155.4 177.34 11.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.888 0.375 . . . . 0.0 110.989 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.434 ' O ' ' O ' ' A' ' 13' ' ' CYS . 46.8 t -126.89 139.15 52.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.64 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -113.64 108.25 16.88 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 119.88 -0.728 . . . . 0.0 110.973 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 21.4 t -88.86 149.58 23.3 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.56 -41.65 95.64 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.373 -0.918 . . . . 0.0 111.064 -178.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.66 -41.46 64.57 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.976 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -152.39 159.42 32.71 Favored Pre-proline 0 N--CA 1.464 0.233 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -178.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -82.0 122.5 3.83 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 N-CA-C 107.071 -1.934 . . . . 0.0 107.071 174.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.434 ' O ' ' O ' ' A' ' 6' ' ' VAL . 24.8 t -135.06 121.42 20.35 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 119.82 -0.752 . . . . 0.0 112.087 -177.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -59.68 -41.88 91.68 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.85 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -172.67 131.4 0.55 Allowed 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.943 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 156.68 -166.67 33.43 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 84.6 m -99.24 128.66 45.39 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 44.1 t -104.67 109.76 21.82 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.624 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -139.18 150.69 45.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.153 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 51.09 40.39 25.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.966 0.412 . . . . 0.0 110.376 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 55.06 36.11 26.21 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.713 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 43.8 ttm180 -147.14 134.41 20.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.146 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 53.1 t -100.45 123.0 44.09 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.397 -0.521 . . . . 0.0 111.029 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 -121.86 135.74 54.91 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.27 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -120.19 75.19 1.08 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.038 179.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.6 tt 170.81 139.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.461 0.112 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.134 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 53.37 38.35 27.65 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.207 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 48.4 t -100.06 120.82 40.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.865 0.364 . . . . 0.0 110.402 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.643 179.978 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.29 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.42 143.46 57.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.764 0.316 . . . . 0.0 110.537 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 28.3 ptm -152.79 160.22 43.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.756 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -179.98 -176.73 47.6 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 51.8 p30 -155.69 174.36 15.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.771 0.32 . . . . 0.0 111.064 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.4 t -128.28 136.73 59.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.502 0.668 . . . . 0.0 110.183 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -105.75 98.03 7.77 Favored 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.183 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 22.2 t -81.44 149.84 28.6 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.56 -41.19 95.4 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 120.178 -1.01 . . . . 0.0 110.993 -178.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.64 -42.78 62.0 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.042 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -152.56 159.61 32.33 Favored Pre-proline 0 N--CA 1.463 0.211 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -178.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -81.77 122.73 3.99 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 N-CA-C 106.805 -2.036 . . . . 0.0 106.805 174.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 29.8 t -136.68 124.03 21.98 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 119.878 -0.729 . . . . 0.0 111.68 -176.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -58.27 -47.64 82.95 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.6 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -170.23 131.92 1.01 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.691 179.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 158.97 -164.69 33.87 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 69.8 m -97.84 127.85 44.07 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 49.3 t -104.96 108.01 19.29 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.467 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -140.73 153.1 45.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.181 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 52.13 39.38 26.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.879 0.371 . . . . 0.0 110.584 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 57.99 25.34 12.13 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.667 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 92.1 mtm180 -139.56 147.14 40.77 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 47.8 t -106.82 125.57 51.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.041 0.448 . . . . 0.0 111.036 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -116.33 135.0 54.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.408 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -121.55 75.33 1.18 Allowed 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.673 -0.411 . . . . 0.0 109.921 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.3 tt 171.24 140.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.348 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 48.4 t0 52.75 40.04 29.74 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.571 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.4 t -142.69 129.66 20.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.738 0.304 . . . . 0.0 110.518 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 . . . . . 0 C--O 1.219 -0.544 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.585 -179.858 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.31 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.85 152.15 35.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.812 0.339 . . . . 0.0 110.701 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 99.6 mtp -129.21 147.19 51.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.772 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -176.55 179.4 47.59 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 52.2 p30 -156.41 176.45 12.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.925 0.393 . . . . 0.0 110.894 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.428 ' O ' ' O ' ' A' ' 13' ' ' CYS . 48.1 t -128.27 139.83 50.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.699 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -114.56 106.19 13.97 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.834 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.0 t -86.93 148.11 25.48 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.43 -40.96 94.98 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.844 -0.903 . . . . 0.0 110.844 -178.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.45 -41.7 66.22 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.919 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -152.54 158.01 33.42 Favored Pre-proline 0 N--CA 1.465 0.305 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -178.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -81.53 122.64 4.09 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 N-CA-C 106.944 -1.983 . . . . 0.0 106.944 174.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.428 ' O ' ' O ' ' A' ' 6' ' ' VAL . 23.5 t -136.15 120.66 18.18 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 119.901 -0.719 . . . . 0.0 112.268 -176.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -57.72 -47.24 82.97 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.481 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 94.5 t80 -168.76 129.89 1.22 Allowed 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.825 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 157.73 -168.22 34.32 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 77.5 m -96.59 129.53 43.96 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 47.2 t -103.58 115.45 30.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.906 0.384 . . . . 0.0 110.611 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 19.4 tpt180 -155.81 150.52 26.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.945 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 57.4 37.66 28.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.064 0.459 . . . . 0.0 110.446 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 56.71 26.25 11.09 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.211 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -139.78 150.23 44.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.314 -0.403 . . . . 0.0 109.927 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 53.9 t -118.5 126.66 52.49 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.853 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 58.4 ttm-85 -125.35 131.26 53.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.45 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -110.86 75.05 0.9 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.2 tt 169.89 148.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.578 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 55.77 37.45 28.88 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 121.004 -0.278 . . . . 0.0 110.925 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 44.1 t -144.67 130.48 19.19 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.321 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 67.5 t0 . . . . . 0 C--O 1.219 -0.54 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.215 -179.864 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.292 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.53 141.98 58.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.79 0.329 . . . . 0.0 110.556 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 98.5 mtp -62.98 -39.95 96.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.453 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.21 1.45 90.38 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 121.271 -0.49 . . . . 0.0 111.996 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -72.74 143.21 48.07 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.799 0.333 . . . . 0.0 110.771 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.442 ' O ' ' O ' ' A' ' 13' ' ' CYS . 60.8 t -115.81 141.57 32.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.184 0.516 . . . . 0.0 110.678 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -121.8 107.26 12.1 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.777 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 52.5 t -88.82 148.05 24.1 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.65 -40.56 92.81 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 120.621 -0.8 . . . . 0.0 111.549 -178.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.49 -43.88 60.03 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 120.43 -0.89 . . . . 0.0 111.527 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -152.76 165.03 18.46 Favored Pre-proline 0 N--CA 1.466 0.341 0 CA-C-O 121.025 0.44 . . . . 0.0 111.862 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -83.38 122.38 3.2 Favored 'Trans proline' 0 C--N 1.302 -1.901 0 C-N-CA 121.554 1.503 . . . . 0.0 108.974 176.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.442 ' O ' ' O ' ' A' ' 6' ' ' VAL . 8.8 t -115.78 113.08 22.95 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.185 -178.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -53.5 -50.01 66.3 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 119.681 -0.807 . . . . 0.0 110.157 -179.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 93.4 t80 -170.94 100.48 0.22 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.313 -0.403 . . . . 0.0 109.926 178.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -178.57 -161.34 26.24 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 64.7 m -101.13 133.96 44.87 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 50.0 t -102.12 111.29 23.52 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.575 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -138.99 146.93 41.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.343 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 47.32 43.98 15.66 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.154 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 50.9 t0 54.51 41.58 31.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.953 0.406 . . . . 0.0 110.289 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 78.1 ttt-85 -145.27 133.35 21.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.879 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -93.74 111.83 23.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.274 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -106.99 130.88 54.57 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.142 -179.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -122.63 75.02 1.23 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.587 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 19.1 tt 178.85 140.15 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.576 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 36.9 t0 48.86 25.76 1.13 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.929 179.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 40.0 t -149.39 132.5 16.31 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.712 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 117.86 -1.067 . . . . 0.0 110.581 179.87 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.231 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 55.64 39.05 30.89 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.892 0.377 . . . . 0.0 110.613 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 60.8 ttm -106.48 127.06 53.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.31 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -177.83 -179.21 47.86 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 50.0 p30 -155.61 177.2 11.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.902 0.382 . . . . 0.0 111.024 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 53.6 t -103.13 144.97 13.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.387 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -139.15 125.39 20.18 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 12.8 t -104.75 143.31 33.28 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.64 -39.39 93.34 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.51 -0.636 . . . . 0.0 111.51 -178.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.23 -39.67 71.44 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.86 155.62 33.84 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.817 0.341 . . . . 0.0 111.421 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -82.77 122.37 3.45 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 N-CA-C 107.895 -1.617 . . . . 0.0 107.895 175.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 19.7 t -143.46 112.42 6.63 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.544 -178.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -57.75 -44.9 86.42 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.54 -178.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -153.3 132.81 12.93 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.908 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 150.97 -169.93 30.71 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 78.3 m -102.36 130.13 49.01 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.7 t -105.45 111.79 24.64 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.426 -0.509 . . . . 0.0 111.178 -179.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -140.13 149.02 42.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.821 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 51.48 38.55 22.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.962 0.411 . . . . 0.0 110.335 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 57.5 30.43 18.68 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.221 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 86.0 mtp180 -138.46 147.31 43.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.242 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 42.9 t -106.7 123.1 47.63 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.201 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 66.1 ttt180 -121.47 136.09 54.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.309 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -123.21 74.97 1.27 Allowed 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.749 -0.381 . . . . 0.0 110.326 178.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.5 tt 173.27 140.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.946 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 55.36 35.76 25.65 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.283 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 53.1 t -120.14 127.3 52.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.29 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 68.3 t0 . . . . . 0 C--O 1.22 -0.46 0 CA-C-O 118.003 -0.998 . . . . 0.0 110.25 179.811 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.29 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.47 142.18 58.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.779 0.323 . . . . 0.0 110.754 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 66.4 mtt -129.77 148.05 51.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.454 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -178.88 179.22 48.89 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 52.4 p30 -154.61 170.29 21.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.815 0.34 . . . . 0.0 110.965 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 33.3 m -133.57 157.65 42.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.241 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -121.06 103.05 8.73 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.569 -0.453 . . . . 0.0 110.928 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.7 t -77.83 147.28 35.26 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 178.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.94 -40.57 93.42 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 120.112 -1.042 . . . . 0.0 110.537 -178.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.59 -41.4 65.41 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.119 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -152.16 160.59 31.19 Favored Pre-proline 0 N--CA 1.466 0.337 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -178.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -82.42 122.64 3.67 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 N-CA-C 106.802 -2.038 . . . . 0.0 106.802 174.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 33.2 t -136.99 125.25 23.19 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 119.796 -0.762 . . . . 0.0 111.946 -176.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -59.11 -46.82 87.32 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.39 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -173.03 132.89 0.52 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.605 179.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 156.79 -164.39 32.65 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 84.6 m -98.54 129.94 45.1 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.1 t -106.07 109.51 21.48 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.732 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 68.1 mtp85 -140.66 153.1 45.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.093 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 52.38 38.75 25.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.987 0.422 . . . . 0.0 110.667 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 58.12 25.42 12.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.588 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 91.5 mtm180 -139.56 145.82 39.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.166 178.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 51.4 t -107.29 125.04 50.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.97 0.415 . . . . 0.0 111.118 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 58.3 ttm-85 -121.06 130.32 53.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.389 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -111.86 75.17 0.9 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 178.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.6 tt 169.44 148.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.474 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 50.2 t0 54.78 42.19 31.35 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.123 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 44.5 t -144.74 130.3 18.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.921 0.391 . . . . 0.0 110.531 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 . . . . . 0 C--O 1.221 -0.437 0 CA-C-O 118.077 -0.963 . . . . 0.0 110.516 -179.764 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.35 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.05 154.61 39.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.826 0.346 . . . . 0.0 110.461 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 67.1 ttp -112.74 128.76 56.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.699 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -177.06 179.54 47.92 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 50.8 p30 -156.59 174.35 15.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.865 0.364 . . . . 0.0 111.008 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.423 ' O ' ' O ' ' A' ' 13' ' ' CYS . 49.3 t -128.96 140.34 49.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.652 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -110.99 104.86 13.48 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.794 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 16.4 t -84.98 149.36 25.66 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.5 -41.59 95.49 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 120.424 -0.893 . . . . 0.0 111.311 -178.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.64 -41.64 64.43 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.844 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -152.47 160.57 31.06 Favored Pre-proline 0 CA--C 1.519 -0.22 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.054 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -82.71 122.38 3.48 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 N-CA-C 107.139 -1.908 . . . . 0.0 107.139 174.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.423 ' O ' ' O ' ' A' ' 6' ' ' VAL . 21.1 t -139.17 122.08 16.63 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 119.596 -0.842 . . . . 0.0 112.015 -177.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -57.31 -47.3 81.86 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.743 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -168.1 128.51 1.33 Allowed 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.551 179.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 165.07 -168.37 39.18 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.6 t -95.69 117.28 30.2 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 48.9 t -98.43 107.68 20.2 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.206 -0.598 . . . . 0.0 110.677 -179.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 85.5 mtp180 -140.56 152.99 45.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.954 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 52.39 38.21 24.6 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.91 0.386 . . . . 0.0 110.469 179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 58.31 26.67 14.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.661 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 91.2 mtm180 -139.99 146.24 38.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.514 179.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 54.1 t -101.52 120.71 40.73 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.559 -0.457 . . . . 0.0 110.662 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 -131.26 138.75 49.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.231 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -112.41 75.15 0.9 Allowed 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.511 -0.476 . . . . 0.0 109.949 179.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.9 tt 171.09 147.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.136 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 59.17 18.48 6.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.741 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.1 t -143.72 130.84 20.66 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.241 179.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 118.018 -0.991 . . . . 0.0 110.444 -179.772 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 108.742 -1.743 . . . . 0.0 108.742 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.81 -38.58 85.9 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -143.25 170.84 15.01 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.088 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 84.25 1.84 89.38 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 111.74 -0.544 . . . . 0.0 111.74 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -110.67 131.03 55.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.83 0.315 . . . . 0.0 110.37 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 34.5 m -126.47 158.06 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 120.233 -0.587 . . . . 0.0 111.145 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -125.26 101.18 6.86 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.123 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 20.7 t -77.58 145.0 37.1 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.62 -39.69 93.7 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 -179.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.44 -40.03 68.91 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.558 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -151.79 160.4 31.68 Favored Pre-proline 0 N--CA 1.464 0.273 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -179.169 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -84.3 123.02 2.94 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 106.798 -2.039 . . . . 0.0 106.798 174.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 13.7 t -133.69 124.57 26.94 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 119.503 -0.879 . . . . 0.0 111.369 -176.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -57.1 -50.88 71.41 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 119.633 -0.827 . . . . 0.0 109.685 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -168.77 131.49 1.35 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.286 179.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 157.72 -165.47 33.56 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 79.5 m -99.71 128.82 45.8 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 54.1 t -104.35 110.42 22.65 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.836 -0.345 . . . . 0.0 111.442 -179.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -142.48 152.39 42.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.308 179.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 50.01 42.66 24.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.545 179.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 47.8 t0 56.64 28.42 14.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.945 0.403 . . . . 0.0 111.198 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 91.9 mtm180 -140.54 146.88 38.67 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 54.0 t -120.39 124.42 45.47 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.674 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 58.0 ttm-85 -120.65 131.17 54.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.172 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -109.82 75.06 0.92 Allowed 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 120.237 -0.585 . . . . 0.0 109.554 179.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.1 tt 170.12 148.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.057 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 56.06 35.22 25.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.168 179.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.4 t -145.74 129.13 16.87 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.98 0.419 . . . . 0.0 110.812 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 118.105 -0.95 . . . . 0.0 110.914 179.932 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.86 -41.3 97.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.966 0.412 . . . . 0.0 110.47 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 78.4 mtm -63.2 -39.66 95.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.71 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -74.49 168.63 54.47 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.044 -0.823 . . . . 0.0 111.044 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 52.4 p30 -156.76 178.17 10.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.779 0.323 . . . . 0.0 110.634 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.423 ' O ' ' O ' ' A' ' 13' ' ' CYS . 47.7 t -125.21 138.58 53.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -117.25 108.68 15.94 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 120.029 -0.669 . . . . 0.0 110.923 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 13.1 t -89.28 150.31 22.67 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.85 -41.89 96.33 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 120.437 -0.887 . . . . 0.0 111.363 -178.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.51 -42.51 63.72 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 120.858 -0.686 . . . . 0.0 111.952 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -152.63 161.71 28.46 Favored Pre-proline 0 N--CA 1.463 0.194 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -178.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -84.3 122.66 2.88 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.0 1.8 . . . . 0.0 108.387 175.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.423 ' O ' ' O ' ' A' ' 6' ' ' VAL . 0.5 OUTLIER -128.73 120.9 27.3 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.373 0.606 . . . . 0.0 111.726 -178.182 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -59.14 -41.47 88.37 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.153 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -172.85 125.53 0.46 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.851 178.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 163.75 -166.83 37.58 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.834 -0.907 . . . . 0.0 110.834 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 85.8 m -101.97 131.8 48.16 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.8 t -117.08 120.96 39.96 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.705 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -141.94 139.42 32.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.127 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 54.33 46.15 25.72 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.028 -179.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 55.6 34.25 22.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.592 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 61.8 ttp180 -141.96 129.34 21.2 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 46.3 t -101.5 121.54 42.15 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.188 -179.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 58.7 ttm-85 -118.44 131.11 56.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.367 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -112.66 74.84 0.88 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.4 HD13 HG21 ' A' ' 26' ' ' ILE . 10.5 tt 169.26 148.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.733 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 50.0 t0 55.41 41.59 30.87 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.227 179.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 50.1 t -144.94 130.19 18.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.35 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 . . . . . 0 C--O 1.221 -0.402 0 CA-C-O 118.039 -0.981 . . . . 0.0 110.581 -179.865 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.338 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.93 142.48 58.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.742 0.306 . . . . 0.0 110.649 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 60.6 ttm -109.59 127.87 54.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.518 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 179.98 -178.72 48.67 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 50.5 p30 -156.01 177.45 11.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.92 0.39 . . . . 0.0 110.993 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.2 t -127.5 140.13 49.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.848 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -116.14 97.73 6.23 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 119.996 -0.682 . . . . 0.0 110.798 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 21.6 t -77.76 146.02 36.12 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.94 -40.41 93.2 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 120.048 -1.073 . . . . 0.0 110.879 -178.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.59 -40.93 66.37 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 120.851 -0.69 . . . . 0.0 111.715 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -152.13 159.42 32.92 Favored Pre-proline 0 N--CA 1.465 0.279 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -178.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -82.43 122.49 3.63 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 N-CA-C 106.94 -1.985 . . . . 0.0 106.94 174.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 27.1 t -136.32 122.24 20.05 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 119.793 -0.763 . . . . 0.0 112.13 -177.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -59.98 -41.78 92.76 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.57 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -173.86 133.22 0.44 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.788 0.328 . . . . 0.0 110.7 179.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 155.34 -165.75 32.46 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 70.7 m -98.89 128.67 45.14 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 44.8 t -102.91 108.65 19.93 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.625 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -139.94 151.08 45.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.972 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 50.64 40.91 25.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.751 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 55.19 33.61 20.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.807 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 44.4 ttm180 -146.87 135.2 21.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.071 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 53.2 t -99.32 121.91 41.74 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.279 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -111.81 135.08 52.9 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.599 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -121.16 75.33 1.15 Allowed 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.003 179.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.8 tt 171.17 140.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.383 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 39.1 t0 52.95 39.89 30.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.552 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.0 t -142.14 130.63 22.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.763 0.316 . . . . 0.0 110.586 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 54.7 p30 . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 118.073 -0.965 . . . . 0.0 110.604 -179.993 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 21.6 t . . . . . 0 N--CA 1.457 -0.113 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.02 -39.56 94.42 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -178.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.19 -39.72 71.86 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.62 157.78 40.9 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-O 121.063 0.458 . . . . 0.0 112.07 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -83.35 122.0 3.14 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 N-CA-C 108.262 -1.476 . . . . 0.0 108.262 175.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 19.7 t -149.71 111.59 4.57 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -59.99 -40.05 87.82 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -178.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -156.68 133.25 10.08 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.954 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 148.39 -168.9 29.05 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 78.3 m -102.65 127.71 49.64 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.861 -0.335 . . . . 0.0 110.142 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 50.8 t -104.15 114.1 28.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.049 0.452 . . . . 0.0 110.894 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -138.9 146.83 41.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.274 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 49.63 41.37 21.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.751 0.31 . . . . 0.0 110.685 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 55.92 35.82 26.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.005 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 32.4 tpt180 -146.7 131.98 18.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.121 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 43.6 t -95.31 121.52 37.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.011 0.434 . . . . 0.0 110.716 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 58.6 ttm-85 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.596 -179.966 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.1 t . . . . . 0 N--CA 1.455 -0.22 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.08 -40.31 95.44 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.699 -178.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.4 -39.89 69.42 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 120.93 -0.652 . . . . 0.0 111.474 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -152.42 156.88 33.76 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.563 0.22 . . . . 0.0 111.526 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -82.83 122.32 3.42 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 N-CA-C 107.882 -1.622 . . . . 0.0 107.882 175.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 18.0 t -141.89 116.01 9.39 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.977 -178.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 58.2 mtmt -61.6 -40.06 93.46 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.689 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -160.32 130.65 5.39 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.829 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 152.26 -172.2 31.5 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 69.1 m -99.39 129.01 45.55 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.7 t -104.16 110.51 22.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.123 0.487 . . . . 0.0 110.853 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -138.65 149.4 45.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.729 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 51.23 39.91 24.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.936 0.398 . . . . 0.0 110.324 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 56.72 30.02 16.85 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.299 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -139.09 144.95 38.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.078 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 47.6 t -105.38 121.21 43.43 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.635 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.837 -179.853 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 16.5 t . . . . . 0 C--O 1.232 0.147 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.1 -40.48 93.64 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 120.808 -0.71 . . . . 0.0 111.59 -178.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.3 -41.28 68.76 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 120.454 -0.879 . . . . 0.0 111.417 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -149.1 159.42 37.21 Favored Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -84.23 122.26 2.84 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 N-CA-C 108.026 -1.567 . . . . 0.0 108.026 175.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 22.7 t -143.4 117.41 9.43 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.805 -178.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -60.29 -45.23 94.08 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.419 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -159.45 130.24 5.9 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.079 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 156.12 -166.94 33.23 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 83.2 m -102.02 127.13 49.03 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 47.2 t -102.86 110.45 22.38 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.693 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -138.61 148.87 44.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.0 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 50.09 40.98 22.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.92 0.39 . . . . 0.0 110.482 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 54.69 33.07 18.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.892 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 78.3 ttt-85 -143.0 134.08 25.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.962 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 45.5 t -97.34 120.79 38.35 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.803 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.45 179.919 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 12.8 t . . . . . 0 C--O 1.231 0.1 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.04 -40.63 95.79 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 121.05 -0.595 . . . . 0.0 111.814 -178.193 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.04 -39.73 73.47 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.408 HG21 ' HA ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -150.41 156.15 36.82 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.852 0.358 . . . . 0.0 111.346 -179.544 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -83.69 122.28 3.06 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 N-CA-C 108.126 -1.529 . . . . 0.0 108.126 175.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 21.0 t -144.25 110.97 5.66 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 120.311 -0.556 . . . . 0.0 110.299 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -60.07 -40.34 89.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.95 -178.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 93.6 t80 -154.28 130.9 10.68 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.101 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 149.41 -171.0 29.62 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 79.5 m -101.66 130.46 48.02 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 49.9 t -104.8 111.58 24.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.099 0.476 . . . . 0.0 111.093 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -138.37 148.27 44.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.087 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 50.42 40.67 23.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.854 0.359 . . . . 0.0 110.48 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 56.76 30.67 18.08 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.171 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.408 ' HA ' HG21 ' A' ' 11' ' ' VAL . 99.7 mtt180 -139.47 147.07 40.83 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 42.6 t -108.47 124.08 49.87 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.445 -0.502 . . . . 0.0 111.09 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.582 179.872 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 10.5 t . . . . . 0 N--CA 1.456 -0.132 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.05 -39.41 94.28 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.618 -178.347 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.26 -39.73 71.09 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.93 152.44 31.7 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 120.724 0.297 . . . . 0.0 111.471 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -81.04 122.19 4.19 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 N-CA-C 107.692 -1.695 . . . . 0.0 107.692 175.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 18.4 t -142.75 111.27 6.21 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.623 -177.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -57.36 -45.63 84.18 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.642 -178.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 93.6 t80 -152.86 130.37 11.44 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.822 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 154.48 -171.44 32.95 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.7 m -102.48 126.73 49.62 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 50.5 t -104.03 118.21 36.12 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.995 -179.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -152.92 144.67 23.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.643 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 57.07 37.57 28.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.855 0.36 . . . . 0.0 110.299 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 57.85 29.67 17.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.468 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -137.56 149.44 46.71 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 52.1 t -117.22 126.11 52.23 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.132 0.491 . . . . 0.0 110.844 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.431 -179.968 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.9 t . . . . . 0 N--CA 1.454 -0.275 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.51 -41.65 95.54 Favored Glycine 0 CA--C 1.523 0.535 0 C-N-CA 120.347 -0.93 . . . . 0.0 111.299 -178.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.57 -41.63 65.1 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 120.766 -0.73 . . . . 0.0 111.968 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -152.37 158.71 33.41 Favored Pre-proline 0 N--CA 1.464 0.226 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -178.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -81.81 122.65 3.96 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 N-CA-C 106.815 -2.033 . . . . 0.0 106.815 174.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 26.0 t -135.33 121.03 19.53 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 119.748 -0.781 . . . . 0.0 112.216 -177.036 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -59.43 -41.45 89.62 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.838 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 93.5 t80 -173.04 131.17 0.49 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.718 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 157.93 -166.01 33.85 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 71.8 m -99.62 127.75 45.72 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 48.9 t -104.05 110.19 22.26 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.454 -0.499 . . . . 0.0 110.667 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -139.32 151.35 46.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.799 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 51.84 39.16 25.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.886 0.374 . . . . 0.0 110.368 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 57.37 29.22 16.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.09 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -139.19 148.05 42.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.357 -0.383 . . . . 0.0 109.97 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 52.3 t -111.8 125.6 54.18 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.205 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.433 179.391 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.8 t . . . . . 0 N--CA 1.456 -0.174 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.46 -40.4 96.12 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.669 -178.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.46 -40.03 68.64 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.319 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.94 154.67 34.65 Favored Pre-proline 0 C--N 1.329 -0.303 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -179.292 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -81.42 122.39 4.07 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 N-CA-C 107.955 -1.594 . . . . 0.0 107.955 175.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 18.1 t -143.2 111.97 6.47 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.313 -178.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -58.0 -45.84 86.19 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.491 -178.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -153.05 129.83 10.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.816 0.341 . . . . 0.0 110.718 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 154.08 -172.68 32.72 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.7 m -100.31 128.2 46.43 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 49.9 t -103.33 111.49 23.93 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.967 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -139.54 147.64 41.5 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.12 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 49.8 43.28 24.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.893 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 53.52 34.92 19.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.792 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -145.17 134.1 22.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.868 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 45.9 t -99.08 123.86 43.68 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.193 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.744 179.452 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 16.2 t . . . . . 0 N--CA 1.456 -0.164 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.46 -39.37 94.8 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.24 -40.05 71.07 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.11 157.12 46.62 Favored Pre-proline 0 C--N 1.331 -0.223 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -179.087 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -83.26 122.26 3.23 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 N-CA-C 108.215 -1.494 . . . . 0.0 108.215 176.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 24.1 t -151.36 110.99 4.01 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 120.589 -0.445 . . . . 0.0 110.159 -178.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -60.67 -40.45 92.16 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 111.779 0.288 . . . . 0.0 111.779 -179.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 94.7 t80 -154.02 134.19 13.28 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.058 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 147.49 -170.58 28.24 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 86.5 m -102.05 129.31 48.33 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 47.1 t -103.82 111.7 24.34 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.026 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -140.75 148.7 41.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.582 179.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 50.94 40.56 25.47 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.927 0.394 . . . . 0.0 110.862 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 58.68 25.04 12.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.063 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 91.8 mtm180 -138.64 144.81 39.86 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.218 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 45.7 t -103.39 123.19 46.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.955 0.407 . . . . 0.0 111.126 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 65.2 ttt180 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.143 179.626 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 48.8 t . . . . . 0 C--O 1.23 0.068 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.23 -40.98 94.61 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.21 -177.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.38 -41.39 67.69 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 120.47 -0.871 . . . . 0.0 111.652 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -152.72 163.01 24.88 Favored Pre-proline 0 CA--C 1.515 -0.369 0 CA-C-O 120.956 0.408 . . . . 0.0 111.696 -179.317 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -84.24 122.24 2.83 Favored 'Trans proline' 0 C--N 1.301 -1.928 0 C-N-CA 121.326 1.351 . . . . 0.0 109.191 176.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -133.5 111.32 10.61 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.98 -179.014 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -57.89 -40.88 81.36 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.34 -178.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 93.4 t80 -148.08 119.4 7.83 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.741 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 168.78 -170.5 42.38 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.429 -1.069 . . . . 0.0 110.429 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.9 m -105.5 127.73 53.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.972 0.415 . . . . 0.0 110.903 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 44.7 t -104.75 114.52 28.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.989 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.2 tpt180 -146.74 137.35 23.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.325 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 51.75 41.81 29.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.637 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 57.48 39.25 28.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.239 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -139.14 144.33 38.6 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.512 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 17.2 t -108.05 124.88 50.86 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.887 0.375 . . . . 0.0 110.615 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.633 -179.883 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 31.3 t . . . . . 0 N--CA 1.454 -0.227 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.92 -40.73 95.68 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -179.035 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.49 -40.43 67.92 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 121.011 -0.614 . . . . 0.0 111.696 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.7 152.99 60.96 Favored Pre-proline 0 N--CA 1.464 0.267 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -179.275 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -81.84 122.54 3.92 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 N-CA-C 108.004 -1.575 . . . . 0.0 108.004 175.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 44.5 t -146.69 130.32 16.93 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.57 -177.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 58.4 mtmt -63.23 -42.24 99.21 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.233 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -173.25 134.29 0.53 Allowed 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.937 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 156.73 -166.26 33.32 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.939 -0.865 . . . . 0.0 110.939 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 78.9 m -94.8 130.61 41.29 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 41.9 t -106.21 116.33 31.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.008 0.432 . . . . 0.0 110.828 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.1 tpt180 -145.46 139.36 26.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.324 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 52.86 43.85 31.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.279 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 56.79 33.02 22.33 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.304 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -138.41 147.54 43.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.003 179.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 43.2 t -119.37 127.45 53.16 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.995 0.426 . . . . 0.0 111.098 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 69.0 ttt180 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.178 179.537 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 21.4 t . . . . . 0 N--CA 1.453 -0.283 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.56 -41.65 95.64 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.373 -0.918 . . . . 0.0 111.064 -178.278 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.66 -41.46 64.57 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.976 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -152.39 159.42 32.71 Favored Pre-proline 0 N--CA 1.464 0.233 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -178.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -82.0 122.5 3.83 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 N-CA-C 107.071 -1.934 . . . . 0.0 107.071 174.535 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 24.8 t -135.06 121.42 20.35 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 119.82 -0.752 . . . . 0.0 112.087 -177.004 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -59.68 -41.88 91.68 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.85 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -172.67 131.4 0.55 Allowed 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.943 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 156.68 -166.67 33.43 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 84.6 m -99.24 128.66 45.39 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 44.1 t -104.67 109.76 21.82 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.624 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -139.18 150.69 45.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.153 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 51.09 40.39 25.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.966 0.412 . . . . 0.0 110.376 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 55.06 36.11 26.21 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.713 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 43.8 ttm180 -147.14 134.41 20.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.146 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 53.1 t -100.45 123.0 44.09 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.397 -0.521 . . . . 0.0 111.029 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 . . . . . 0 C--N 1.331 -0.21 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.27 179.647 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 22.2 t . . . . . 0 N--CA 1.452 -0.344 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.56 -41.19 95.4 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 120.178 -1.01 . . . . 0.0 110.993 -178.282 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.64 -42.78 62.0 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.042 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -152.56 159.61 32.33 Favored Pre-proline 0 N--CA 1.463 0.211 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -178.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -81.77 122.73 3.99 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 N-CA-C 106.805 -2.036 . . . . 0.0 106.805 174.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 29.8 t -136.68 124.03 21.98 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 119.878 -0.729 . . . . 0.0 111.68 -176.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -58.27 -47.64 82.95 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.6 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -170.23 131.92 1.01 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.691 179.268 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 158.97 -164.69 33.87 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 69.8 m -97.84 127.85 44.07 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 49.3 t -104.96 108.01 19.29 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.467 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -140.73 153.1 45.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.181 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 52.13 39.38 26.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.879 0.371 . . . . 0.0 110.584 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 57.99 25.34 12.13 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.667 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 92.1 mtm180 -139.56 147.14 40.77 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 47.8 t -106.82 125.57 51.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.041 0.448 . . . . 0.0 111.036 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.408 179.792 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.0 t . . . . . 0 N--CA 1.454 -0.241 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.43 -40.96 94.98 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.844 -0.903 . . . . 0.0 110.844 -178.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.45 -41.7 66.22 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.919 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -152.54 158.01 33.42 Favored Pre-proline 0 N--CA 1.465 0.305 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -178.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -81.53 122.64 4.09 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 N-CA-C 106.944 -1.983 . . . . 0.0 106.944 174.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 23.5 t -136.15 120.66 18.18 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 119.901 -0.719 . . . . 0.0 112.268 -176.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -57.72 -47.24 82.97 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.481 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 94.5 t80 -168.76 129.89 1.22 Allowed 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.825 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 157.73 -168.22 34.32 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 77.5 m -96.59 129.53 43.96 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 47.2 t -103.58 115.45 30.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.906 0.384 . . . . 0.0 110.611 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 19.4 tpt180 -155.81 150.52 26.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.945 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 57.4 37.66 28.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.064 0.459 . . . . 0.0 110.446 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 56.71 26.25 11.09 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.211 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -139.78 150.23 44.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.314 -0.403 . . . . 0.0 109.927 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 53.9 t -118.5 126.66 52.49 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.853 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 58.4 ttm-85 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.45 179.866 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 52.5 t . . . . . 0 N--CA 1.455 -0.21 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.65 -40.56 92.81 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 120.621 -0.8 . . . . 0.0 111.549 -178.099 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.49 -43.88 60.03 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 120.43 -0.89 . . . . 0.0 111.527 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -152.76 165.03 18.46 Favored Pre-proline 0 N--CA 1.466 0.341 0 CA-C-O 121.025 0.44 . . . . 0.0 111.862 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -83.38 122.38 3.2 Favored 'Trans proline' 0 C--N 1.302 -1.901 0 C-N-CA 121.554 1.503 . . . . 0.0 108.974 176.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 8.8 t -115.78 113.08 22.95 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.185 -178.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -53.5 -50.01 66.3 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 119.681 -0.807 . . . . 0.0 110.157 -179.082 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 93.4 t80 -170.94 100.48 0.22 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.313 -0.403 . . . . 0.0 109.926 178.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -178.57 -161.34 26.24 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 64.7 m -101.13 133.96 44.87 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 50.0 t -102.12 111.29 23.52 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.575 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -138.99 146.93 41.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.343 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 47.32 43.98 15.66 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.154 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 50.9 t0 54.51 41.58 31.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.953 0.406 . . . . 0.0 110.289 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 78.1 ttt-85 -145.27 133.35 21.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.879 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -93.74 111.83 23.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.274 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 . . . . . 0 C--N 1.332 -0.18 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.142 -179.501 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 12.8 t . . . . . 0 N--CA 1.456 -0.142 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.64 -39.39 93.34 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.51 -0.636 . . . . 0.0 111.51 -178.324 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.23 -39.67 71.44 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.86 155.62 33.84 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.817 0.341 . . . . 0.0 111.421 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -82.77 122.37 3.45 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 N-CA-C 107.895 -1.617 . . . . 0.0 107.895 175.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 19.7 t -143.46 112.42 6.63 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.544 -178.088 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -57.75 -44.9 86.42 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.54 -178.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -153.3 132.81 12.93 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.908 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 150.97 -169.93 30.71 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 78.3 m -102.36 130.13 49.01 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.7 t -105.45 111.79 24.64 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.426 -0.509 . . . . 0.0 111.178 -179.394 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -140.13 149.02 42.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.821 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 51.48 38.55 22.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.962 0.411 . . . . 0.0 110.335 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 57.5 30.43 18.68 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.221 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 86.0 mtp180 -138.46 147.31 43.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.242 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 42.9 t -106.7 123.1 47.63 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.201 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 66.1 ttt180 . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.309 179.767 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.7 t . . . . . 0 N--CA 1.451 -0.421 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.94 -40.57 93.42 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 120.112 -1.042 . . . . 0.0 110.537 -178.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.59 -41.4 65.41 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.119 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -152.16 160.59 31.19 Favored Pre-proline 0 N--CA 1.466 0.337 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -178.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -82.42 122.64 3.67 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 N-CA-C 106.802 -2.038 . . . . 0.0 106.802 174.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 33.2 t -136.99 125.25 23.19 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 119.796 -0.762 . . . . 0.0 111.946 -176.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -59.11 -46.82 87.32 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.39 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -173.03 132.89 0.52 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.605 179.447 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 156.79 -164.39 32.65 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 84.6 m -98.54 129.94 45.1 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.1 t -106.07 109.51 21.48 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.732 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 68.1 mtp85 -140.66 153.1 45.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.093 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 52.38 38.75 25.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.987 0.422 . . . . 0.0 110.667 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 58.12 25.42 12.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.588 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 91.5 mtm180 -139.56 145.82 39.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.166 178.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 51.4 t -107.29 125.04 50.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.97 0.415 . . . . 0.0 111.118 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 58.3 ttm-85 . . . . . 0 C--N 1.331 -0.223 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.389 179.785 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 16.4 t . . . . . 0 N--CA 1.452 -0.345 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.5 -41.59 95.49 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 120.424 -0.893 . . . . 0.0 111.311 -178.216 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.64 -41.64 64.43 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.844 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -152.47 160.57 31.06 Favored Pre-proline 0 CA--C 1.519 -0.22 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.054 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -82.71 122.38 3.48 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 N-CA-C 107.139 -1.908 . . . . 0.0 107.139 174.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 21.1 t -139.17 122.08 16.63 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 119.596 -0.842 . . . . 0.0 112.015 -177.489 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -57.31 -47.3 81.86 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.743 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -168.1 128.51 1.33 Allowed 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.551 179.204 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 165.07 -168.37 39.18 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.6 t -95.69 117.28 30.2 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 48.9 t -98.43 107.68 20.2 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.206 -0.598 . . . . 0.0 110.677 -179.329 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 85.5 mtp180 -140.56 152.99 45.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.954 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 52.39 38.21 24.6 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.91 0.386 . . . . 0.0 110.469 179.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 58.31 26.67 14.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.661 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 91.2 mtm180 -139.99 146.24 38.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.514 179.009 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 54.1 t -101.52 120.71 40.73 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.559 -0.457 . . . . 0.0 110.662 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.231 -179.563 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 20.7 t . . . . . 0 N--CA 1.455 -0.209 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.62 -39.69 93.7 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 -179.09 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.44 -40.03 68.91 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.558 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -151.79 160.4 31.68 Favored Pre-proline 0 N--CA 1.464 0.273 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -179.169 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -84.3 123.02 2.94 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 106.798 -2.039 . . . . 0.0 106.798 174.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 13.7 t -133.69 124.57 26.94 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 119.503 -0.879 . . . . 0.0 111.369 -176.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -57.1 -50.88 71.41 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 119.633 -0.827 . . . . 0.0 109.685 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -168.77 131.49 1.35 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.286 179.103 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 157.72 -165.47 33.56 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 79.5 m -99.71 128.82 45.8 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 54.1 t -104.35 110.42 22.65 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.836 -0.345 . . . . 0.0 111.442 -179.146 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -142.48 152.39 42.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.308 179.08 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 50.01 42.66 24.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.545 179.242 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 47.8 t0 56.64 28.42 14.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.945 0.403 . . . . 0.0 111.198 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 91.9 mtm180 -140.54 146.88 38.67 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.259 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 54.0 t -120.39 124.42 45.47 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.674 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 58.0 ttm-85 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.172 179.804 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 13.1 t . . . . . 0 N--CA 1.45 -0.436 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.85 -41.89 96.33 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 120.437 -0.887 . . . . 0.0 111.363 -178.301 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.51 -42.51 63.72 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 120.858 -0.686 . . . . 0.0 111.952 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -152.63 161.71 28.46 Favored Pre-proline 0 N--CA 1.463 0.194 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -178.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -84.3 122.66 2.88 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.0 1.8 . . . . 0.0 108.387 175.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -128.73 120.9 27.3 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.373 0.606 . . . . 0.0 111.726 -178.182 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -59.14 -41.47 88.37 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.153 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -172.85 125.53 0.46 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.851 178.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 163.75 -166.83 37.58 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.834 -0.907 . . . . 0.0 110.834 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 85.8 m -101.97 131.8 48.16 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.8 t -117.08 120.96 39.96 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.705 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -141.94 139.42 32.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.127 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 54.33 46.15 25.72 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.028 -179.344 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 55.6 34.25 22.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.592 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 61.8 ttp180 -141.96 129.34 21.2 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.197 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 46.3 t -101.5 121.54 42.15 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.188 -179.428 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 58.7 ttm-85 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.367 179.937 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 21.6 t . . . . . 0 N--CA 1.452 -0.353 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.94 -40.41 93.2 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 120.048 -1.073 . . . . 0.0 110.879 -178.146 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.59 -40.93 66.37 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 120.851 -0.69 . . . . 0.0 111.715 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -152.13 159.42 32.92 Favored Pre-proline 0 N--CA 1.465 0.279 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -178.827 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -82.43 122.49 3.63 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 N-CA-C 106.94 -1.985 . . . . 0.0 106.94 174.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 27.1 t -136.32 122.24 20.05 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 119.793 -0.763 . . . . 0.0 112.13 -177.277 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -59.98 -41.78 92.76 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.57 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -173.86 133.22 0.44 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.788 0.328 . . . . 0.0 110.7 179.2 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 155.34 -165.75 32.46 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 70.7 m -98.89 128.67 45.14 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 44.8 t -102.91 108.65 19.93 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.625 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -139.94 151.08 45.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.972 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 50.64 40.91 25.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.751 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 55.19 33.61 20.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.807 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 44.4 ttm180 -146.87 135.2 21.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.071 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 53.2 t -99.32 121.91 41.74 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.279 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 . . . . . 0 C--N 1.332 -0.191 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.599 179.656 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.399 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.27 142.81 58.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.876 0.37 . . . . 0.0 110.928 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 79.0 mtm -63.0 -39.69 95.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.628 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.06 16.61 80.57 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.457 -0.657 . . . . 0.0 111.457 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 51.0 p-10 -83.49 176.77 8.81 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.047 0.451 . . . . 0.0 110.95 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.667 HG12 ' O ' ' A' ' 14' ' ' LYS . 8.9 p -139.82 159.04 27.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.686 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.435 ' N ' HG22 ' A' ' 6' ' ' VAL . 81.7 m-20 -137.44 147.26 45.21 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 21.6 t -108.15 141.59 39.64 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.02 -39.56 94.42 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -178.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.19 -39.72 71.86 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.62 157.78 40.9 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-O 121.063 0.458 . . . . 0.0 112.07 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -83.35 122.0 3.14 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 N-CA-C 108.262 -1.476 . . . . 0.0 108.262 175.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 19.7 t -149.71 111.59 4.57 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.667 ' O ' HG12 ' A' ' 6' ' ' VAL . 68.4 mttm -59.99 -40.05 87.82 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -178.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -156.68 133.25 10.08 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.954 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 148.39 -168.9 29.05 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 78.3 m -102.65 127.71 49.64 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.861 -0.335 . . . . 0.0 110.142 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 50.8 t -104.15 114.1 28.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.049 0.452 . . . . 0.0 110.894 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -138.9 146.83 41.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.274 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 49.63 41.37 21.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.751 0.31 . . . . 0.0 110.685 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 55.92 35.82 26.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.005 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 32.4 tpt180 -146.7 131.98 18.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.121 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 43.6 t -95.31 121.52 37.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.011 0.434 . . . . 0.0 110.716 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 58.6 ttm-85 -116.89 131.34 56.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.596 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -111.33 75.0 0.89 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 11.7 tt 169.64 149.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.555 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 55.44 37.97 29.63 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.296 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 41.9 t -148.68 131.53 16.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.877 0.37 . . . . 0.0 110.538 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 66.8 t0 . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 118.104 -0.951 . . . . 0.0 110.375 179.879 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.51 141.79 58.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.913 0.387 . . . . 0.0 110.572 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.3 mmt -130.19 149.8 51.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.624 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -77.02 170.66 55.16 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 47.5 p30 -157.24 176.14 13.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.899 0.381 . . . . 0.0 110.907 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.5 t -127.19 137.9 56.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.166 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -138.25 132.75 32.22 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.587 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.1 t -109.81 145.69 36.29 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.08 -40.31 95.44 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.699 -178.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.4 -39.89 69.42 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 120.93 -0.652 . . . . 0.0 111.474 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -152.42 156.88 33.76 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.563 0.22 . . . . 0.0 111.526 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -82.83 122.32 3.42 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 N-CA-C 107.882 -1.622 . . . . 0.0 107.882 175.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 18.0 t -141.89 116.01 9.39 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.977 -178.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 58.2 mtmt -61.6 -40.06 93.46 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.689 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -160.32 130.65 5.39 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.829 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 152.26 -172.2 31.5 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 69.1 m -99.39 129.01 45.55 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.7 t -104.16 110.51 22.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.123 0.487 . . . . 0.0 110.853 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -138.65 149.4 45.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.729 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 51.23 39.91 24.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.936 0.398 . . . . 0.0 110.324 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 56.72 30.02 16.85 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.299 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -139.09 144.95 38.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.078 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 47.6 t -105.38 121.21 43.43 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.635 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -109.84 133.04 53.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.837 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -122.86 74.7 1.22 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.0 tt 169.79 127.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 O-C-N 123.927 0.767 . . . . 0.0 110.498 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 50.72 38.88 20.54 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.914 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 43.4 t -61.49 -48.4 81.24 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.389 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.754 -179.889 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.25 152.51 37.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.822 0.344 . . . . 0.0 110.572 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 60.4 ttm -109.67 126.47 53.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.781 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -82.7 -179.67 52.8 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 51.6 p30 -155.95 175.78 13.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.951 0.405 . . . . 0.0 110.817 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 53.1 t -125.97 137.72 56.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.891 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -135.95 126.57 27.11 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.589 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 16.5 t -100.74 143.75 30.53 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.1 -40.48 93.64 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 120.808 -0.71 . . . . 0.0 111.59 -178.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.3 -41.28 68.76 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 120.454 -0.879 . . . . 0.0 111.417 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -149.1 159.42 37.21 Favored Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -84.23 122.26 2.84 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 N-CA-C 108.026 -1.567 . . . . 0.0 108.026 175.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 22.7 t -143.4 117.41 9.43 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.805 -178.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -60.29 -45.23 94.08 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.419 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -159.45 130.24 5.9 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.079 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 156.12 -166.94 33.23 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 83.2 m -102.02 127.13 49.03 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 47.2 t -102.86 110.45 22.38 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.693 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -138.61 148.87 44.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.0 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 50.09 40.98 22.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.92 0.39 . . . . 0.0 110.482 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 54.69 33.07 18.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.892 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 78.3 ttt-85 -143.0 134.08 25.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.962 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 45.5 t -97.34 120.79 38.35 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.803 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -109.1 134.56 51.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.45 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -119.42 74.99 1.03 Allowed 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.271 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.9 tt 171.42 142.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.422 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 52.77 37.51 24.08 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.7 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.5 t -145.97 130.72 18.02 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.517 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.546 179.972 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.388 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.94 -40.03 94.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.855 0.359 . . . . 0.0 110.694 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 79.0 mtm 53.97 40.66 31.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.57 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.47 177.95 53.97 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -108.57 137.7 46.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.803 0.335 . . . . 0.0 110.752 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 44.0 t -97.17 144.05 11.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.489 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -139.33 129.33 25.04 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 12.8 t -107.46 144.36 34.52 Favored 'General case' 0 C--O 1.231 0.1 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.04 -40.63 95.79 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 121.05 -0.595 . . . . 0.0 111.814 -178.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.04 -39.73 73.47 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.408 HG21 ' HA ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -150.41 156.15 36.82 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.852 0.358 . . . . 0.0 111.346 -179.544 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -83.69 122.28 3.06 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 N-CA-C 108.126 -1.529 . . . . 0.0 108.126 175.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 21.0 t -144.25 110.97 5.66 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 120.311 -0.556 . . . . 0.0 110.299 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -60.07 -40.34 89.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.95 -178.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 93.6 t80 -154.28 130.9 10.68 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.101 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 149.41 -171.0 29.62 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 79.5 m -101.66 130.46 48.02 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 49.9 t -104.8 111.58 24.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.099 0.476 . . . . 0.0 111.093 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -138.37 148.27 44.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.087 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 50.42 40.67 23.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.854 0.359 . . . . 0.0 110.48 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 56.76 30.67 18.08 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.171 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.408 ' HA ' HG21 ' A' ' 11' ' ' VAL . 99.7 mtt180 -139.47 147.07 40.83 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 42.6 t -108.47 124.08 49.87 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.445 -0.502 . . . . 0.0 111.09 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.487 ' HE ' HG23 ' A' ' 26' ' ' ILE . 71.9 ttt180 -121.44 136.4 54.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.582 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -121.31 75.0 1.14 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.66 -0.416 . . . . 0.0 109.999 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.487 HG23 ' HE ' ' A' ' 24' ' ' ARG . 5.3 tt 169.75 140.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.192 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 49.8 t0 51.63 41.98 29.27 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.233 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 53.7 t -99.57 119.41 38.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.795 0.331 . . . . 0.0 110.351 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 65.6 t0 . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.504 -179.82 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.381 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.51 153.96 36.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.864 0.364 . . . . 0.0 110.571 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 79.5 mtm -131.47 146.27 52.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.477 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -177.13 -178.32 46.74 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 52.8 p30 -155.56 177.72 11.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.74 0.305 . . . . 0.0 110.601 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 46.3 t -102.29 144.3 13.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.382 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -138.98 127.16 22.61 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 10.5 t -107.12 143.34 35.42 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.05 -39.41 94.28 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.618 -178.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.26 -39.73 71.09 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.93 152.44 31.7 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 120.724 0.297 . . . . 0.0 111.471 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -81.04 122.19 4.19 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 N-CA-C 107.692 -1.695 . . . . 0.0 107.692 175.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 18.4 t -142.75 111.27 6.21 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.623 -177.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -57.36 -45.63 84.18 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.642 -178.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 93.6 t80 -152.86 130.37 11.44 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.822 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 154.48 -171.44 32.95 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.7 m -102.48 126.73 49.62 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 50.5 t -104.03 118.21 36.12 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.995 -179.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -152.92 144.67 23.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.643 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 57.07 37.57 28.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.855 0.36 . . . . 0.0 110.299 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 57.85 29.67 17.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.468 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -137.56 149.44 46.71 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 52.1 t -117.22 126.11 52.23 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.132 0.491 . . . . 0.0 110.844 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -117.82 136.38 53.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.431 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -122.58 75.17 1.24 Allowed 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.04 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.0 tt 171.25 141.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.082 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 53.54 35.19 20.2 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.546 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 41.9 t -141.32 130.11 22.96 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.508 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 . . . . . 0 C--O 1.221 -0.447 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.749 -179.899 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.346 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.25 143.25 58.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.84 0.352 . . . . 0.0 110.588 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.9 ptp -153.91 161.35 42.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.575 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -177.55 179.54 48.16 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 51.3 p30 -155.61 177.04 11.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.798 0.332 . . . . 0.0 111.003 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.423 ' O ' ' O ' ' A' ' 13' ' ' CYS . 46.9 t -127.48 139.86 50.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -114.23 108.57 17.13 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.892 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.9 t -89.88 149.44 22.64 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.51 -41.65 95.54 Favored Glycine 0 CA--C 1.523 0.535 0 C-N-CA 120.347 -0.93 . . . . 0.0 111.299 -178.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.57 -41.63 65.1 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 120.766 -0.73 . . . . 0.0 111.968 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -152.37 158.71 33.41 Favored Pre-proline 0 N--CA 1.464 0.226 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -178.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -81.81 122.65 3.96 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 N-CA-C 106.815 -2.033 . . . . 0.0 106.815 174.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.423 ' O ' ' O ' ' A' ' 6' ' ' VAL . 26.0 t -135.33 121.03 19.53 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 119.748 -0.781 . . . . 0.0 112.216 -177.036 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -59.43 -41.45 89.62 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.838 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 93.5 t80 -173.04 131.17 0.49 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.718 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 157.93 -166.01 33.85 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 71.8 m -99.62 127.75 45.72 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 48.9 t -104.05 110.19 22.26 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.454 -0.499 . . . . 0.0 110.667 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -139.32 151.35 46.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.799 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 51.84 39.16 25.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.886 0.374 . . . . 0.0 110.368 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 57.37 29.22 16.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.09 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -139.19 148.05 42.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.357 -0.383 . . . . 0.0 109.97 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 52.3 t -111.8 125.6 54.18 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.205 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -117.13 131.52 56.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.433 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -122.77 75.25 1.26 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.417 HG23 ' O ' ' A' ' 26' ' ' ILE . 11.5 tt 171.54 127.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.156 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 51.02 36.61 15.65 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.365 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 44.4 t -61.4 -47.8 84.15 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.324 -0.551 . . . . 0.0 110.632 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 117.961 -1.018 . . . . 0.0 110.538 179.876 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.26 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.83 142.0 58.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.859 0.362 . . . . 0.0 110.509 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 95.9 mmm -62.57 -39.64 94.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.465 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.69 -173.02 52.44 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 52.5 p30 -154.51 175.04 14.09 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.778 0.323 . . . . 0.0 110.701 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.7 t -102.8 146.1 11.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.194 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -139.05 126.81 22.05 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.8 t -105.04 145.87 29.88 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.46 -40.4 96.12 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.669 -178.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.46 -40.03 68.64 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.319 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.94 154.67 34.65 Favored Pre-proline 0 C--N 1.329 -0.303 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -179.292 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -81.42 122.39 4.07 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 N-CA-C 107.955 -1.594 . . . . 0.0 107.955 175.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 18.1 t -143.2 111.97 6.47 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.313 -178.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -58.0 -45.84 86.19 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.491 -178.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -153.05 129.83 10.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.816 0.341 . . . . 0.0 110.718 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 154.08 -172.68 32.72 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.7 m -100.31 128.2 46.43 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 49.9 t -103.33 111.49 23.93 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.967 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -139.54 147.64 41.5 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.12 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 49.8 43.28 24.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.893 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 53.52 34.92 19.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.792 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -145.17 134.1 22.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.868 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 45.9 t -99.08 123.86 43.68 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.193 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -105.74 140.66 38.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.744 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -122.25 117.68 26.72 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.3 tp 85.08 155.26 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 O-C-N 125.122 1.514 . . . . 0.0 109.89 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 51.5 t0 59.49 43.44 16.19 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -178.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 49.9 t -116.64 124.3 49.43 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.534 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 . . . . . 0 C--O 1.221 -0.435 0 CA-C-O 117.922 -1.037 . . . . 0.0 110.392 179.829 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.61 144.14 57.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.729 0.299 . . . . 0.0 110.466 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.4 ptt? -154.12 160.89 42.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.465 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -177.34 179.21 48.2 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 53.1 p30 -155.01 171.13 20.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.109 0.48 . . . . 0.0 110.996 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.626 HG12 ' O ' ' A' ' 14' ' ' LYS . 9.1 p -138.91 159.56 30.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.324 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.435 ' N ' HG22 ' A' ' 6' ' ' VAL . 52.2 p30 -139.7 157.31 45.97 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.437 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 16.2 t -117.69 140.44 49.66 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.46 -39.37 94.8 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.24 -40.05 71.07 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.11 157.12 46.62 Favored Pre-proline 0 C--N 1.331 -0.223 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -179.087 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -83.26 122.26 3.23 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 N-CA-C 108.215 -1.494 . . . . 0.0 108.215 176.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 24.1 t -151.36 110.99 4.01 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 120.589 -0.445 . . . . 0.0 110.159 -178.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.626 ' O ' HG12 ' A' ' 6' ' ' VAL . 98.2 mttt -60.67 -40.45 92.16 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 111.779 0.288 . . . . 0.0 111.779 -179.108 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 94.7 t80 -154.02 134.19 13.28 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.058 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 147.49 -170.58 28.24 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 86.5 m -102.05 129.31 48.33 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 47.1 t -103.82 111.7 24.34 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.026 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -140.75 148.7 41.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.582 179.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 50.94 40.56 25.47 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.927 0.394 . . . . 0.0 110.862 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 58.68 25.04 12.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.063 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 91.8 mtm180 -138.64 144.81 39.86 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.218 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 45.7 t -103.39 123.19 46.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.955 0.407 . . . . 0.0 111.126 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 65.2 ttt180 -119.56 134.92 55.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.143 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -121.58 75.22 1.17 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.128 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 12.5 tt 171.47 139.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.796 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 53.2 t0 52.47 42.14 31.13 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.993 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 51.9 t -108.22 123.31 48.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.765 0.317 . . . . 0.0 110.527 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 67.1 t0 . . . . . 0 C--O 1.219 -0.539 0 CA-C-O 117.931 -1.033 . . . . 0.0 110.186 179.793 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.334 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.73 151.73 30.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.73 0.3 . . . . 0.0 110.389 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 64.1 mtt -131.5 150.32 52.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.742 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -72.61 159.4 53.63 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -70.48 140.69 51.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.879 0.371 . . . . 0.0 110.536 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 54.7 t -76.28 146.3 9.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.404 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -139.62 136.34 34.25 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.387 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 48.8 t -113.58 146.75 39.22 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.23 -40.98 94.61 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.21 -177.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.38 -41.39 67.69 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 120.47 -0.871 . . . . 0.0 111.652 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -152.72 163.01 24.88 Favored Pre-proline 0 CA--C 1.515 -0.369 0 CA-C-O 120.956 0.408 . . . . 0.0 111.696 -179.317 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -84.24 122.24 2.83 Favored 'Trans proline' 0 C--N 1.301 -1.928 0 C-N-CA 121.326 1.351 . . . . 0.0 109.191 176.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -133.5 111.32 10.61 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.98 -179.014 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -57.89 -40.88 81.36 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.34 -178.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 93.4 t80 -148.08 119.4 7.83 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.741 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 168.78 -170.5 42.38 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.429 -1.069 . . . . 0.0 110.429 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.9 m -105.5 127.73 53.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.972 0.415 . . . . 0.0 110.903 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 44.7 t -104.75 114.52 28.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.989 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.2 tpt180 -146.74 137.35 23.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.325 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 51.75 41.81 29.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.637 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 57.48 39.25 28.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.239 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -139.14 144.33 38.6 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.512 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 17.2 t -108.05 124.88 50.86 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.887 0.375 . . . . 0.0 110.615 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.401 ' HG2' HG22 ' A' ' 26' ' ' ILE . 60.3 ttt180 -115.2 134.45 55.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.633 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -118.21 74.93 0.98 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.33 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.401 HG22 ' HG2' ' A' ' 24' ' ' ARG . 18.0 tt 177.03 138.29 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.443 178.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 53.32 30.35 10.05 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.078 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 39.2 t -121.28 127.4 51.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.829 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 . . . . . 0 C--O 1.22 -0.471 0 CA-C-O 117.845 -1.074 . . . . 0.0 110.114 179.742 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.338 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.424 ' HB3' ' HB3' ' A' ' 5' ' ' ASN . . . -67.15 142.74 56.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.002 0.429 . . . . 0.0 110.764 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 60.5 ttm -69.68 130.26 41.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.324 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 81.7 5.16 90.07 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.161 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.424 ' HB3' ' HB3' ' A' ' 2' ' ' ALA . 45.1 p-10 -77.88 164.08 25.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 117.318 0.559 . . . . 0.0 110.596 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.4 p -158.52 124.44 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.403 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.187 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -86.99 138.8 31.2 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.696 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 31.3 t -91.98 143.23 26.69 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.258 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.92 -40.73 95.68 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -179.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.49 -40.43 67.92 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 121.011 -0.614 . . . . 0.0 111.696 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.7 152.99 60.96 Favored Pre-proline 0 N--CA 1.464 0.267 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -179.275 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -81.84 122.54 3.92 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 N-CA-C 108.004 -1.575 . . . . 0.0 108.004 175.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 44.5 t -146.69 130.32 16.93 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.57 -177.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 58.4 mtmt -63.23 -42.24 99.21 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.233 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -173.25 134.29 0.53 Allowed 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.937 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 156.73 -166.26 33.32 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.939 -0.865 . . . . 0.0 110.939 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 78.9 m -94.8 130.61 41.29 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 41.9 t -106.21 116.33 31.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.008 0.432 . . . . 0.0 110.828 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.1 tpt180 -145.46 139.36 26.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.324 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 52.86 43.85 31.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.279 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 56.79 33.02 22.33 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.304 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -138.41 147.54 43.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.003 179.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 43.2 t -119.37 127.45 53.16 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.995 0.426 . . . . 0.0 111.098 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 69.0 ttt180 -128.91 136.31 50.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.178 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -123.96 75.09 1.33 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.9 tt 169.01 132.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.721 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 56.14 27.07 10.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.322 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 45.8 t -61.84 -48.06 82.28 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.79 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 . . . . . 0 C--O 1.22 -0.5 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.646 -179.828 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.04 142.72 58.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.766 0.317 . . . . 0.0 110.574 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 28.0 ttt -111.71 127.55 55.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.709 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.12 177.65 54.25 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 52.4 p30 -155.4 177.34 11.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.888 0.375 . . . . 0.0 110.989 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.434 ' O ' ' O ' ' A' ' 13' ' ' CYS . 46.8 t -126.89 139.15 52.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.64 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -113.64 108.25 16.88 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 119.88 -0.728 . . . . 0.0 110.973 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 21.4 t -88.86 149.58 23.3 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.56 -41.65 95.64 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.373 -0.918 . . . . 0.0 111.064 -178.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.66 -41.46 64.57 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.976 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -152.39 159.42 32.71 Favored Pre-proline 0 N--CA 1.464 0.233 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -178.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -82.0 122.5 3.83 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 N-CA-C 107.071 -1.934 . . . . 0.0 107.071 174.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.434 ' O ' ' O ' ' A' ' 6' ' ' VAL . 24.8 t -135.06 121.42 20.35 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 119.82 -0.752 . . . . 0.0 112.087 -177.004 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -59.68 -41.88 91.68 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.85 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -172.67 131.4 0.55 Allowed 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.943 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 156.68 -166.67 33.43 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 84.6 m -99.24 128.66 45.39 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 44.1 t -104.67 109.76 21.82 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.624 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -139.18 150.69 45.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.153 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 51.09 40.39 25.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.966 0.412 . . . . 0.0 110.376 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 55.06 36.11 26.21 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.713 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 43.8 ttm180 -147.14 134.41 20.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.146 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 53.1 t -100.45 123.0 44.09 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.397 -0.521 . . . . 0.0 111.029 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.427 ' NE ' HG23 ' A' ' 26' ' ' ILE . 70.5 ttt180 -121.86 135.74 54.91 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.27 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -120.19 75.19 1.08 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.038 179.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.427 HG23 ' NE ' ' A' ' 24' ' ' ARG . 5.6 tt 170.81 139.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.461 0.112 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.134 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 53.37 38.35 27.65 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.207 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 48.4 t -100.06 120.82 40.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.865 0.364 . . . . 0.0 110.402 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.643 179.978 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.29 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.42 143.46 57.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.764 0.316 . . . . 0.0 110.537 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 28.3 ptm -152.79 160.22 43.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.756 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -179.98 -176.73 47.6 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 51.8 p30 -155.69 174.36 15.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.771 0.32 . . . . 0.0 111.064 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.4 t -128.28 136.73 59.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.502 0.668 . . . . 0.0 110.183 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -105.75 98.03 7.77 Favored 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.183 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 22.2 t -81.44 149.84 28.6 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.56 -41.19 95.4 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 120.178 -1.01 . . . . 0.0 110.993 -178.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.64 -42.78 62.0 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.042 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -152.56 159.61 32.33 Favored Pre-proline 0 N--CA 1.463 0.211 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -178.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -81.77 122.73 3.99 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 N-CA-C 106.805 -2.036 . . . . 0.0 106.805 174.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 29.8 t -136.68 124.03 21.98 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 119.878 -0.729 . . . . 0.0 111.68 -176.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -58.27 -47.64 82.95 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.6 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -170.23 131.92 1.01 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.691 179.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 158.97 -164.69 33.87 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 69.8 m -97.84 127.85 44.07 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 49.3 t -104.96 108.01 19.29 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.467 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -140.73 153.1 45.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.181 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 52.13 39.38 26.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.879 0.371 . . . . 0.0 110.584 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 57.99 25.34 12.13 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.667 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 92.1 mtm180 -139.56 147.14 40.77 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 47.8 t -106.82 125.57 51.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.041 0.448 . . . . 0.0 111.036 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -116.33 135.0 54.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.408 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -121.55 75.33 1.18 Allowed 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.673 -0.411 . . . . 0.0 109.921 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.3 tt 171.24 140.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.348 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 48.4 t0 52.75 40.04 29.74 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.571 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.4 t -142.69 129.66 20.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.738 0.304 . . . . 0.0 110.518 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 . . . . . 0 C--O 1.219 -0.544 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.585 -179.858 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.31 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.85 152.15 35.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.812 0.339 . . . . 0.0 110.701 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 99.6 mtp -129.21 147.19 51.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.772 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -176.55 179.4 47.59 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 52.2 p30 -156.41 176.45 12.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.925 0.393 . . . . 0.0 110.894 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.428 ' O ' ' O ' ' A' ' 13' ' ' CYS . 48.1 t -128.27 139.83 50.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.699 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -114.56 106.19 13.97 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.834 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.0 t -86.93 148.11 25.48 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.43 -40.96 94.98 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.844 -0.903 . . . . 0.0 110.844 -178.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.45 -41.7 66.22 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.919 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -152.54 158.01 33.42 Favored Pre-proline 0 N--CA 1.465 0.305 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -178.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -81.53 122.64 4.09 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 N-CA-C 106.944 -1.983 . . . . 0.0 106.944 174.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.428 ' O ' ' O ' ' A' ' 6' ' ' VAL . 23.5 t -136.15 120.66 18.18 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 119.901 -0.719 . . . . 0.0 112.268 -176.673 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -57.72 -47.24 82.97 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.481 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 94.5 t80 -168.76 129.89 1.22 Allowed 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.825 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 157.73 -168.22 34.32 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 77.5 m -96.59 129.53 43.96 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 47.2 t -103.58 115.45 30.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.906 0.384 . . . . 0.0 110.611 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 19.4 tpt180 -155.81 150.52 26.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.945 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 57.4 37.66 28.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.064 0.459 . . . . 0.0 110.446 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 56.71 26.25 11.09 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.211 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -139.78 150.23 44.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.314 -0.403 . . . . 0.0 109.927 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 53.9 t -118.5 126.66 52.49 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.853 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 58.4 ttm-85 -125.35 131.26 53.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.45 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -110.86 75.05 0.9 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.2 tt 169.89 148.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.578 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 55.77 37.45 28.88 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 121.004 -0.278 . . . . 0.0 110.925 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 44.1 t -144.67 130.48 19.19 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.321 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 67.5 t0 . . . . . 0 C--O 1.219 -0.54 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.215 -179.864 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.292 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.53 141.98 58.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.79 0.329 . . . . 0.0 110.556 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 98.5 mtp -62.98 -39.95 96.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.453 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.21 1.45 90.38 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 121.271 -0.49 . . . . 0.0 111.996 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -72.74 143.21 48.07 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.799 0.333 . . . . 0.0 110.771 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.442 ' O ' ' O ' ' A' ' 13' ' ' CYS . 60.8 t -115.81 141.57 32.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.184 0.516 . . . . 0.0 110.678 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -121.8 107.26 12.1 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.777 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 52.5 t -88.82 148.05 24.1 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.65 -40.56 92.81 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 120.621 -0.8 . . . . 0.0 111.549 -178.099 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.49 -43.88 60.03 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 120.43 -0.89 . . . . 0.0 111.527 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -152.76 165.03 18.46 Favored Pre-proline 0 N--CA 1.466 0.341 0 CA-C-O 121.025 0.44 . . . . 0.0 111.862 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -83.38 122.38 3.2 Favored 'Trans proline' 0 C--N 1.302 -1.901 0 C-N-CA 121.554 1.503 . . . . 0.0 108.974 176.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.442 ' O ' ' O ' ' A' ' 6' ' ' VAL . 8.8 t -115.78 113.08 22.95 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.185 -178.344 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -53.5 -50.01 66.3 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 119.681 -0.807 . . . . 0.0 110.157 -179.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 93.4 t80 -170.94 100.48 0.22 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.313 -0.403 . . . . 0.0 109.926 178.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -178.57 -161.34 26.24 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 64.7 m -101.13 133.96 44.87 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 50.0 t -102.12 111.29 23.52 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.575 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -138.99 146.93 41.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.343 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 47.32 43.98 15.66 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.154 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 50.9 t0 54.51 41.58 31.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.953 0.406 . . . . 0.0 110.289 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 78.1 ttt-85 -145.27 133.35 21.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.879 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -93.74 111.83 23.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.274 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -106.99 130.88 54.57 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.142 -179.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -122.63 75.02 1.23 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.587 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 19.1 tt 178.85 140.15 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.576 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 36.9 t0 48.86 25.76 1.13 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.929 179.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 40.0 t -149.39 132.5 16.31 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.712 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 117.86 -1.067 . . . . 0.0 110.581 179.87 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.231 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 55.64 39.05 30.89 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.892 0.377 . . . . 0.0 110.613 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 60.8 ttm -106.48 127.06 53.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.31 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -177.83 -179.21 47.86 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 50.0 p30 -155.61 177.2 11.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.902 0.382 . . . . 0.0 111.024 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 53.6 t -103.13 144.97 13.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.387 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -139.15 125.39 20.18 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.066 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 12.8 t -104.75 143.31 33.28 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.64 -39.39 93.34 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.51 -0.636 . . . . 0.0 111.51 -178.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.23 -39.67 71.44 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.86 155.62 33.84 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.817 0.341 . . . . 0.0 111.421 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -82.77 122.37 3.45 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 N-CA-C 107.895 -1.617 . . . . 0.0 107.895 175.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 19.7 t -143.46 112.42 6.63 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.544 -178.088 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -57.75 -44.9 86.42 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.54 -178.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -153.3 132.81 12.93 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.908 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 150.97 -169.93 30.71 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 78.3 m -102.36 130.13 49.01 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.7 t -105.45 111.79 24.64 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.426 -0.509 . . . . 0.0 111.178 -179.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -140.13 149.02 42.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.821 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 51.48 38.55 22.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.962 0.411 . . . . 0.0 110.335 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 57.5 30.43 18.68 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.221 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 86.0 mtp180 -138.46 147.31 43.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.242 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 42.9 t -106.7 123.1 47.63 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.201 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 66.1 ttt180 -121.47 136.09 54.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.309 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -123.21 74.97 1.27 Allowed 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.749 -0.381 . . . . 0.0 110.326 178.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.5 tt 173.27 140.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.946 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 55.36 35.76 25.65 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.283 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 53.1 t -120.14 127.3 52.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.29 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 68.3 t0 . . . . . 0 C--O 1.22 -0.46 0 CA-C-O 118.003 -0.998 . . . . 0.0 110.25 179.811 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.29 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.47 142.18 58.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.779 0.323 . . . . 0.0 110.754 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 66.4 mtt -129.77 148.05 51.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.454 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -178.88 179.22 48.89 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 52.4 p30 -154.61 170.29 21.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.815 0.34 . . . . 0.0 110.965 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 33.3 m -133.57 157.65 42.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.241 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -121.06 103.05 8.73 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.569 -0.453 . . . . 0.0 110.928 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.7 t -77.83 147.28 35.26 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 178.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.94 -40.57 93.42 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 120.112 -1.042 . . . . 0.0 110.537 -178.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.59 -41.4 65.41 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.119 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -152.16 160.59 31.19 Favored Pre-proline 0 N--CA 1.466 0.337 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -178.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -82.42 122.64 3.67 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 N-CA-C 106.802 -2.038 . . . . 0.0 106.802 174.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 33.2 t -136.99 125.25 23.19 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 119.796 -0.762 . . . . 0.0 111.946 -176.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -59.11 -46.82 87.32 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.39 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -173.03 132.89 0.52 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.605 179.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 156.79 -164.39 32.65 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 84.6 m -98.54 129.94 45.1 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.1 t -106.07 109.51 21.48 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.732 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 68.1 mtp85 -140.66 153.1 45.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.093 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 52.38 38.75 25.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.987 0.422 . . . . 0.0 110.667 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 58.12 25.42 12.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.588 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 91.5 mtm180 -139.56 145.82 39.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.166 178.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 51.4 t -107.29 125.04 50.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.97 0.415 . . . . 0.0 111.118 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 58.3 ttm-85 -121.06 130.32 53.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.389 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -111.86 75.17 0.9 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 178.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.6 tt 169.44 148.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.474 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 50.2 t0 54.78 42.19 31.35 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.123 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 44.5 t -144.74 130.3 18.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.921 0.391 . . . . 0.0 110.531 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 . . . . . 0 C--O 1.221 -0.437 0 CA-C-O 118.077 -0.963 . . . . 0.0 110.516 -179.764 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.35 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.05 154.61 39.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.826 0.346 . . . . 0.0 110.461 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 67.1 ttp -112.74 128.76 56.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.699 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -177.06 179.54 47.92 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 50.8 p30 -156.59 174.35 15.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.865 0.364 . . . . 0.0 111.008 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.423 ' O ' ' O ' ' A' ' 13' ' ' CYS . 49.3 t -128.96 140.34 49.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.652 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -110.99 104.86 13.48 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.794 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 16.4 t -84.98 149.36 25.66 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.5 -41.59 95.49 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 120.424 -0.893 . . . . 0.0 111.311 -178.216 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.64 -41.64 64.43 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.844 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -152.47 160.57 31.06 Favored Pre-proline 0 CA--C 1.519 -0.22 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.054 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -82.71 122.38 3.48 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 N-CA-C 107.139 -1.908 . . . . 0.0 107.139 174.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.423 ' O ' ' O ' ' A' ' 6' ' ' VAL . 21.1 t -139.17 122.08 16.63 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 119.596 -0.842 . . . . 0.0 112.015 -177.489 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -57.31 -47.3 81.86 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.743 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -168.1 128.51 1.33 Allowed 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.551 179.204 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 165.07 -168.37 39.18 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.6 t -95.69 117.28 30.2 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 48.9 t -98.43 107.68 20.2 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.206 -0.598 . . . . 0.0 110.677 -179.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 85.5 mtp180 -140.56 152.99 45.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.954 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 52.39 38.21 24.6 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.91 0.386 . . . . 0.0 110.469 179.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 58.31 26.67 14.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.661 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 91.2 mtm180 -139.99 146.24 38.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.514 179.009 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 54.1 t -101.52 120.71 40.73 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.559 -0.457 . . . . 0.0 110.662 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.46 ' HG2' HG22 ' A' ' 26' ' ' ILE . 68.1 ttt180 -131.26 138.75 49.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.231 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -112.41 75.15 0.9 Allowed 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.511 -0.476 . . . . 0.0 109.949 179.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.46 HG22 ' HG2' ' A' ' 24' ' ' ARG . 6.9 tt 171.09 147.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.136 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 59.17 18.48 6.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.741 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.1 t -143.72 130.84 20.66 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.241 179.063 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 118.018 -0.991 . . . . 0.0 110.444 -179.772 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 108.742 -1.743 . . . . 0.0 108.742 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.81 -38.58 85.9 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -143.25 170.84 15.01 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.088 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 84.25 1.84 89.38 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 111.74 -0.544 . . . . 0.0 111.74 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -110.67 131.03 55.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.83 0.315 . . . . 0.0 110.37 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 34.5 m -126.47 158.06 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 120.233 -0.587 . . . . 0.0 111.145 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -125.26 101.18 6.86 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.123 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 20.7 t -77.58 145.0 37.1 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.62 -39.69 93.7 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 -179.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.44 -40.03 68.91 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.558 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -151.79 160.4 31.68 Favored Pre-proline 0 N--CA 1.464 0.273 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -179.169 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -84.3 123.02 2.94 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 106.798 -2.039 . . . . 0.0 106.798 174.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 13.7 t -133.69 124.57 26.94 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 119.503 -0.879 . . . . 0.0 111.369 -176.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -57.1 -50.88 71.41 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 119.633 -0.827 . . . . 0.0 109.685 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -168.77 131.49 1.35 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.286 179.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 157.72 -165.47 33.56 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 79.5 m -99.71 128.82 45.8 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 54.1 t -104.35 110.42 22.65 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.836 -0.345 . . . . 0.0 111.442 -179.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -142.48 152.39 42.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.308 179.08 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 50.01 42.66 24.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.545 179.242 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 47.8 t0 56.64 28.42 14.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.945 0.403 . . . . 0.0 111.198 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 91.9 mtm180 -140.54 146.88 38.67 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 54.0 t -120.39 124.42 45.47 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.674 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 58.0 ttm-85 -120.65 131.17 54.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.172 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -109.82 75.06 0.92 Allowed 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 120.237 -0.585 . . . . 0.0 109.554 179.016 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.1 tt 170.12 148.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.057 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 56.06 35.22 25.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.168 179.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.4 t -145.74 129.13 16.87 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.98 0.419 . . . . 0.0 110.812 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 118.105 -0.95 . . . . 0.0 110.914 179.932 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.86 -41.3 97.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.966 0.412 . . . . 0.0 110.47 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 78.4 mtm -63.2 -39.66 95.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.71 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -74.49 168.63 54.47 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.044 -0.823 . . . . 0.0 111.044 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 52.4 p30 -156.76 178.17 10.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.779 0.323 . . . . 0.0 110.634 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.423 ' O ' ' O ' ' A' ' 13' ' ' CYS . 47.7 t -125.21 138.58 53.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -117.25 108.68 15.94 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 120.029 -0.669 . . . . 0.0 110.923 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 13.1 t -89.28 150.31 22.67 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.85 -41.89 96.33 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 120.437 -0.887 . . . . 0.0 111.363 -178.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.51 -42.51 63.72 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 120.858 -0.686 . . . . 0.0 111.952 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -152.63 161.71 28.46 Favored Pre-proline 0 N--CA 1.463 0.194 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -178.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -84.3 122.66 2.88 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.0 1.8 . . . . 0.0 108.387 175.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.423 ' O ' ' O ' ' A' ' 6' ' ' VAL . 0.5 OUTLIER -128.73 120.9 27.3 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.373 0.606 . . . . 0.0 111.726 -178.182 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -59.14 -41.47 88.37 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.153 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -172.85 125.53 0.46 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.851 178.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 163.75 -166.83 37.58 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.834 -0.907 . . . . 0.0 110.834 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 85.8 m -101.97 131.8 48.16 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.8 t -117.08 120.96 39.96 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.705 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -141.94 139.42 32.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.127 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 54.33 46.15 25.72 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.028 -179.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 55.6 34.25 22.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.592 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 61.8 ttp180 -141.96 129.34 21.2 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.197 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 46.3 t -101.5 121.54 42.15 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.188 -179.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 58.7 ttm-85 -118.44 131.11 56.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.367 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -112.66 74.84 0.88 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.5 tt 169.26 148.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.733 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 50.0 t0 55.41 41.59 30.87 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.227 179.24 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 50.1 t -144.94 130.19 18.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.35 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 . . . . . 0 C--O 1.221 -0.402 0 CA-C-O 118.039 -0.981 . . . . 0.0 110.581 -179.865 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.338 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.93 142.48 58.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.742 0.306 . . . . 0.0 110.649 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 60.6 ttm -109.59 127.87 54.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.518 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 179.98 -178.72 48.67 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 50.5 p30 -156.01 177.45 11.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.92 0.39 . . . . 0.0 110.993 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.2 t -127.5 140.13 49.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.848 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -116.14 97.73 6.23 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 119.996 -0.682 . . . . 0.0 110.798 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 21.6 t -77.76 146.02 36.12 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.94 -40.41 93.2 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 120.048 -1.073 . . . . 0.0 110.879 -178.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.59 -40.93 66.37 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 120.851 -0.69 . . . . 0.0 111.715 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -152.13 159.42 32.92 Favored Pre-proline 0 N--CA 1.465 0.279 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -178.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -82.43 122.49 3.63 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 N-CA-C 106.94 -1.985 . . . . 0.0 106.94 174.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 27.1 t -136.32 122.24 20.05 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 119.793 -0.763 . . . . 0.0 112.13 -177.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -59.98 -41.78 92.76 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.57 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -173.86 133.22 0.44 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.788 0.328 . . . . 0.0 110.7 179.2 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 155.34 -165.75 32.46 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 70.7 m -98.89 128.67 45.14 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 44.8 t -102.91 108.65 19.93 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.625 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -139.94 151.08 45.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.972 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 50.64 40.91 25.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.751 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 55.19 33.61 20.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.807 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 44.4 ttm180 -146.87 135.2 21.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.071 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 53.2 t -99.32 121.91 41.74 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.279 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.41 ' HE ' HG23 ' A' ' 26' ' ' ILE . 67.6 ttt180 -111.81 135.08 52.9 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.599 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -121.16 75.33 1.15 Allowed 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.003 179.109 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.41 HG23 ' HE ' ' A' ' 24' ' ' ARG . 6.8 tt 171.17 140.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.383 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 39.1 t0 52.95 39.89 30.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.552 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.0 t -142.14 130.63 22.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.763 0.316 . . . . 0.0 110.586 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 54.7 p30 . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 118.073 -0.965 . . . . 0.0 110.604 -179.993 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 21.6 t . . . . . 0 N--CA 1.457 -0.113 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.02 -39.56 94.42 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -178.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.19 -39.72 71.86 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.62 157.78 40.9 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-O 121.063 0.458 . . . . 0.0 112.07 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -83.35 122.0 3.14 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 N-CA-C 108.262 -1.476 . . . . 0.0 108.262 175.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 19.7 t -149.71 111.59 4.57 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -59.99 -40.05 87.82 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -178.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -156.68 133.25 10.08 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.954 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 148.39 -168.9 29.05 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 78.3 m -102.65 127.71 49.64 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.861 -0.335 . . . . 0.0 110.142 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 50.8 t -104.15 114.1 28.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.049 0.452 . . . . 0.0 110.894 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -138.9 146.83 41.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.274 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 49.63 41.37 21.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.751 0.31 . . . . 0.0 110.685 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 55.92 35.82 26.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.005 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 32.4 tpt180 -146.7 131.98 18.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.121 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 43.6 t -95.31 121.52 37.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.011 0.434 . . . . 0.0 110.716 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 58.6 ttm-85 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.596 -179.966 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.1 t . . . . . 0 N--CA 1.455 -0.22 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.08 -40.31 95.44 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.699 -178.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.4 -39.89 69.42 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 120.93 -0.652 . . . . 0.0 111.474 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -152.42 156.88 33.76 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.563 0.22 . . . . 0.0 111.526 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -82.83 122.32 3.42 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 N-CA-C 107.882 -1.622 . . . . 0.0 107.882 175.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 18.0 t -141.89 116.01 9.39 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.977 -178.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 58.2 mtmt -61.6 -40.06 93.46 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.689 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -160.32 130.65 5.39 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.829 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 152.26 -172.2 31.5 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 69.1 m -99.39 129.01 45.55 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.7 t -104.16 110.51 22.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.123 0.487 . . . . 0.0 110.853 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -138.65 149.4 45.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.729 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 51.23 39.91 24.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.936 0.398 . . . . 0.0 110.324 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 56.72 30.02 16.85 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.299 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -139.09 144.95 38.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.078 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 47.6 t -105.38 121.21 43.43 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.635 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.837 -179.853 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 16.5 t . . . . . 0 C--O 1.232 0.147 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.1 -40.48 93.64 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 120.808 -0.71 . . . . 0.0 111.59 -178.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.3 -41.28 68.76 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 120.454 -0.879 . . . . 0.0 111.417 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -149.1 159.42 37.21 Favored Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -84.23 122.26 2.84 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 N-CA-C 108.026 -1.567 . . . . 0.0 108.026 175.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 22.7 t -143.4 117.41 9.43 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.805 -178.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -60.29 -45.23 94.08 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.419 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -159.45 130.24 5.9 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.079 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 156.12 -166.94 33.23 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 83.2 m -102.02 127.13 49.03 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 47.2 t -102.86 110.45 22.38 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.693 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -138.61 148.87 44.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.0 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 50.09 40.98 22.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.92 0.39 . . . . 0.0 110.482 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 54.69 33.07 18.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.892 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 78.3 ttt-85 -143.0 134.08 25.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.962 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 45.5 t -97.34 120.79 38.35 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.803 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.45 179.919 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 12.8 t . . . . . 0 C--O 1.231 0.1 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.04 -40.63 95.79 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 121.05 -0.595 . . . . 0.0 111.814 -178.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.04 -39.73 73.47 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.408 HG21 ' HA ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -150.41 156.15 36.82 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.852 0.358 . . . . 0.0 111.346 -179.544 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -83.69 122.28 3.06 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 N-CA-C 108.126 -1.529 . . . . 0.0 108.126 175.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 21.0 t -144.25 110.97 5.66 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 120.311 -0.556 . . . . 0.0 110.299 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -60.07 -40.34 89.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.95 -178.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 93.6 t80 -154.28 130.9 10.68 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.101 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 149.41 -171.0 29.62 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 79.5 m -101.66 130.46 48.02 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 49.9 t -104.8 111.58 24.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.099 0.476 . . . . 0.0 111.093 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -138.37 148.27 44.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.087 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 50.42 40.67 23.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.854 0.359 . . . . 0.0 110.48 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 56.76 30.67 18.08 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.171 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.408 ' HA ' HG21 ' A' ' 11' ' ' VAL . 99.7 mtt180 -139.47 147.07 40.83 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 42.6 t -108.47 124.08 49.87 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.445 -0.502 . . . . 0.0 111.09 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.582 179.872 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 10.5 t . . . . . 0 N--CA 1.456 -0.132 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.05 -39.41 94.28 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.618 -178.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.26 -39.73 71.09 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.93 152.44 31.7 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 120.724 0.297 . . . . 0.0 111.471 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -81.04 122.19 4.19 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 N-CA-C 107.692 -1.695 . . . . 0.0 107.692 175.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 18.4 t -142.75 111.27 6.21 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.623 -177.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -57.36 -45.63 84.18 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.642 -178.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 93.6 t80 -152.86 130.37 11.44 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.822 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 154.48 -171.44 32.95 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.7 m -102.48 126.73 49.62 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 50.5 t -104.03 118.21 36.12 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.995 -179.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -152.92 144.67 23.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.643 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 57.07 37.57 28.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.855 0.36 . . . . 0.0 110.299 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 57.85 29.67 17.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.468 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -137.56 149.44 46.71 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 52.1 t -117.22 126.11 52.23 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.132 0.491 . . . . 0.0 110.844 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.431 -179.968 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.9 t . . . . . 0 N--CA 1.454 -0.275 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.51 -41.65 95.54 Favored Glycine 0 CA--C 1.523 0.535 0 C-N-CA 120.347 -0.93 . . . . 0.0 111.299 -178.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.57 -41.63 65.1 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 120.766 -0.73 . . . . 0.0 111.968 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -152.37 158.71 33.41 Favored Pre-proline 0 N--CA 1.464 0.226 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -178.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -81.81 122.65 3.96 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 N-CA-C 106.815 -2.033 . . . . 0.0 106.815 174.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 26.0 t -135.33 121.03 19.53 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 119.748 -0.781 . . . . 0.0 112.216 -177.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -59.43 -41.45 89.62 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.838 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 93.5 t80 -173.04 131.17 0.49 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.718 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 157.93 -166.01 33.85 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 71.8 m -99.62 127.75 45.72 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 48.9 t -104.05 110.19 22.26 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.454 -0.499 . . . . 0.0 110.667 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -139.32 151.35 46.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.799 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 51.84 39.16 25.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.886 0.374 . . . . 0.0 110.368 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 57.37 29.22 16.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.09 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -139.19 148.05 42.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.357 -0.383 . . . . 0.0 109.97 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 52.3 t -111.8 125.6 54.18 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.205 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.433 179.391 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.8 t . . . . . 0 N--CA 1.456 -0.174 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.46 -40.4 96.12 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.669 -178.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.46 -40.03 68.64 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.319 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.94 154.67 34.65 Favored Pre-proline 0 C--N 1.329 -0.303 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -179.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -81.42 122.39 4.07 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 N-CA-C 107.955 -1.594 . . . . 0.0 107.955 175.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 18.1 t -143.2 111.97 6.47 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.313 -178.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -58.0 -45.84 86.19 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.491 -178.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -153.05 129.83 10.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.816 0.341 . . . . 0.0 110.718 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 154.08 -172.68 32.72 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.7 m -100.31 128.2 46.43 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 49.9 t -103.33 111.49 23.93 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.967 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -139.54 147.64 41.5 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.12 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 49.8 43.28 24.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.893 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 53.52 34.92 19.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.792 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -145.17 134.1 22.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.868 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 45.9 t -99.08 123.86 43.68 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.193 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.744 179.452 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 16.2 t . . . . . 0 N--CA 1.456 -0.164 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.46 -39.37 94.8 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.24 -40.05 71.07 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.11 157.12 46.62 Favored Pre-proline 0 C--N 1.331 -0.223 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -179.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -83.26 122.26 3.23 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 N-CA-C 108.215 -1.494 . . . . 0.0 108.215 176.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 24.1 t -151.36 110.99 4.01 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 120.589 -0.445 . . . . 0.0 110.159 -178.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -60.67 -40.45 92.16 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 111.779 0.288 . . . . 0.0 111.779 -179.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 94.7 t80 -154.02 134.19 13.28 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.058 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 147.49 -170.58 28.24 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 86.5 m -102.05 129.31 48.33 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 47.1 t -103.82 111.7 24.34 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.026 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -140.75 148.7 41.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.582 179.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 50.94 40.56 25.47 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.927 0.394 . . . . 0.0 110.862 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 58.68 25.04 12.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.063 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 91.8 mtm180 -138.64 144.81 39.86 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.218 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 45.7 t -103.39 123.19 46.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.955 0.407 . . . . 0.0 111.126 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 65.2 ttt180 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.143 179.626 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 48.8 t . . . . . 0 C--O 1.23 0.068 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.23 -40.98 94.61 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.21 -177.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.38 -41.39 67.69 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 120.47 -0.871 . . . . 0.0 111.652 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -152.72 163.01 24.88 Favored Pre-proline 0 CA--C 1.515 -0.369 0 CA-C-O 120.956 0.408 . . . . 0.0 111.696 -179.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -84.24 122.24 2.83 Favored 'Trans proline' 0 C--N 1.301 -1.928 0 C-N-CA 121.326 1.351 . . . . 0.0 109.191 176.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -133.5 111.32 10.61 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.98 -179.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -57.89 -40.88 81.36 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.34 -178.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 93.4 t80 -148.08 119.4 7.83 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.741 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 168.78 -170.5 42.38 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.429 -1.069 . . . . 0.0 110.429 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.9 m -105.5 127.73 53.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.972 0.415 . . . . 0.0 110.903 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 44.7 t -104.75 114.52 28.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.989 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.2 tpt180 -146.74 137.35 23.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.325 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 51.75 41.81 29.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.637 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 57.48 39.25 28.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.239 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -139.14 144.33 38.6 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.512 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 17.2 t -108.05 124.88 50.86 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.887 0.375 . . . . 0.0 110.615 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.633 -179.883 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 31.3 t . . . . . 0 N--CA 1.454 -0.227 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.92 -40.73 95.68 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -179.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.49 -40.43 67.92 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 121.011 -0.614 . . . . 0.0 111.696 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.7 152.99 60.96 Favored Pre-proline 0 N--CA 1.464 0.267 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -179.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -81.84 122.54 3.92 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 N-CA-C 108.004 -1.575 . . . . 0.0 108.004 175.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 44.5 t -146.69 130.32 16.93 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.57 -177.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 58.4 mtmt -63.23 -42.24 99.21 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.233 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -173.25 134.29 0.53 Allowed 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.937 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 156.73 -166.26 33.32 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.939 -0.865 . . . . 0.0 110.939 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 78.9 m -94.8 130.61 41.29 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 41.9 t -106.21 116.33 31.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.008 0.432 . . . . 0.0 110.828 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.1 tpt180 -145.46 139.36 26.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.324 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 52.86 43.85 31.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.279 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 56.79 33.02 22.33 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.304 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -138.41 147.54 43.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.003 179.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 43.2 t -119.37 127.45 53.16 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.995 0.426 . . . . 0.0 111.098 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 69.0 ttt180 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.178 179.537 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 21.4 t . . . . . 0 N--CA 1.453 -0.283 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.56 -41.65 95.64 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.373 -0.918 . . . . 0.0 111.064 -178.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.66 -41.46 64.57 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.976 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -152.39 159.42 32.71 Favored Pre-proline 0 N--CA 1.464 0.233 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -178.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -82.0 122.5 3.83 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 N-CA-C 107.071 -1.934 . . . . 0.0 107.071 174.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 24.8 t -135.06 121.42 20.35 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 119.82 -0.752 . . . . 0.0 112.087 -177.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -59.68 -41.88 91.68 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.85 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -172.67 131.4 0.55 Allowed 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.943 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 156.68 -166.67 33.43 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 84.6 m -99.24 128.66 45.39 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 44.1 t -104.67 109.76 21.82 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.624 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -139.18 150.69 45.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.153 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 51.09 40.39 25.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.966 0.412 . . . . 0.0 110.376 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 55.06 36.11 26.21 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.713 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 43.8 ttm180 -147.14 134.41 20.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.146 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 53.1 t -100.45 123.0 44.09 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.397 -0.521 . . . . 0.0 111.029 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 . . . . . 0 C--N 1.331 -0.21 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.27 179.647 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 22.2 t . . . . . 0 N--CA 1.452 -0.344 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.56 -41.19 95.4 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 120.178 -1.01 . . . . 0.0 110.993 -178.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.64 -42.78 62.0 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.042 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -152.56 159.61 32.33 Favored Pre-proline 0 N--CA 1.463 0.211 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -178.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -81.77 122.73 3.99 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 N-CA-C 106.805 -2.036 . . . . 0.0 106.805 174.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 29.8 t -136.68 124.03 21.98 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 119.878 -0.729 . . . . 0.0 111.68 -176.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -58.27 -47.64 82.95 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.6 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -170.23 131.92 1.01 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.691 179.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 158.97 -164.69 33.87 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 69.8 m -97.84 127.85 44.07 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 49.3 t -104.96 108.01 19.29 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.467 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -140.73 153.1 45.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.181 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 52.13 39.38 26.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.879 0.371 . . . . 0.0 110.584 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 57.99 25.34 12.13 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.667 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 92.1 mtm180 -139.56 147.14 40.77 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 47.8 t -106.82 125.57 51.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.041 0.448 . . . . 0.0 111.036 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.408 179.792 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.0 t . . . . . 0 N--CA 1.454 -0.241 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.43 -40.96 94.98 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.844 -0.903 . . . . 0.0 110.844 -178.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.45 -41.7 66.22 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.919 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -152.54 158.01 33.42 Favored Pre-proline 0 N--CA 1.465 0.305 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -178.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -81.53 122.64 4.09 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 N-CA-C 106.944 -1.983 . . . . 0.0 106.944 174.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 23.5 t -136.15 120.66 18.18 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 119.901 -0.719 . . . . 0.0 112.268 -176.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -57.72 -47.24 82.97 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.481 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 94.5 t80 -168.76 129.89 1.22 Allowed 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.825 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 157.73 -168.22 34.32 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 77.5 m -96.59 129.53 43.96 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 47.2 t -103.58 115.45 30.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.906 0.384 . . . . 0.0 110.611 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 19.4 tpt180 -155.81 150.52 26.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.945 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 57.4 37.66 28.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.064 0.459 . . . . 0.0 110.446 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 56.71 26.25 11.09 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.211 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -139.78 150.23 44.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.314 -0.403 . . . . 0.0 109.927 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 53.9 t -118.5 126.66 52.49 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.853 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 58.4 ttm-85 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.45 179.866 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 52.5 t . . . . . 0 N--CA 1.455 -0.21 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.65 -40.56 92.81 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 120.621 -0.8 . . . . 0.0 111.549 -178.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.49 -43.88 60.03 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 120.43 -0.89 . . . . 0.0 111.527 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -152.76 165.03 18.46 Favored Pre-proline 0 N--CA 1.466 0.341 0 CA-C-O 121.025 0.44 . . . . 0.0 111.862 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -83.38 122.38 3.2 Favored 'Trans proline' 0 C--N 1.302 -1.901 0 C-N-CA 121.554 1.503 . . . . 0.0 108.974 176.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 8.8 t -115.78 113.08 22.95 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.185 -178.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -53.5 -50.01 66.3 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 119.681 -0.807 . . . . 0.0 110.157 -179.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 93.4 t80 -170.94 100.48 0.22 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.313 -0.403 . . . . 0.0 109.926 178.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -178.57 -161.34 26.24 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 64.7 m -101.13 133.96 44.87 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 50.0 t -102.12 111.29 23.52 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.575 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -138.99 146.93 41.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.343 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 47.32 43.98 15.66 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.154 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 50.9 t0 54.51 41.58 31.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.953 0.406 . . . . 0.0 110.289 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 78.1 ttt-85 -145.27 133.35 21.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.879 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -93.74 111.83 23.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.274 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 . . . . . 0 C--N 1.332 -0.18 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.142 -179.501 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 12.8 t . . . . . 0 N--CA 1.456 -0.142 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.64 -39.39 93.34 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.51 -0.636 . . . . 0.0 111.51 -178.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.23 -39.67 71.44 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.86 155.62 33.84 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.817 0.341 . . . . 0.0 111.421 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -82.77 122.37 3.45 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 N-CA-C 107.895 -1.617 . . . . 0.0 107.895 175.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 19.7 t -143.46 112.42 6.63 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.544 -178.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -57.75 -44.9 86.42 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.54 -178.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -153.3 132.81 12.93 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.908 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 150.97 -169.93 30.71 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 78.3 m -102.36 130.13 49.01 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.7 t -105.45 111.79 24.64 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.426 -0.509 . . . . 0.0 111.178 -179.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -140.13 149.02 42.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.821 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 51.48 38.55 22.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.962 0.411 . . . . 0.0 110.335 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 57.5 30.43 18.68 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.221 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 86.0 mtp180 -138.46 147.31 43.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.242 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 42.9 t -106.7 123.1 47.63 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.201 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 66.1 ttt180 . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.309 179.767 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.7 t . . . . . 0 N--CA 1.451 -0.421 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.94 -40.57 93.42 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 120.112 -1.042 . . . . 0.0 110.537 -178.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.59 -41.4 65.41 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.119 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -152.16 160.59 31.19 Favored Pre-proline 0 N--CA 1.466 0.337 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -178.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -82.42 122.64 3.67 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 N-CA-C 106.802 -2.038 . . . . 0.0 106.802 174.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 33.2 t -136.99 125.25 23.19 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 119.796 -0.762 . . . . 0.0 111.946 -176.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -59.11 -46.82 87.32 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.39 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -173.03 132.89 0.52 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.605 179.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 156.79 -164.39 32.65 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 84.6 m -98.54 129.94 45.1 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.1 t -106.07 109.51 21.48 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.732 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 68.1 mtp85 -140.66 153.1 45.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.093 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 52.38 38.75 25.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.987 0.422 . . . . 0.0 110.667 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 58.12 25.42 12.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.588 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 91.5 mtm180 -139.56 145.82 39.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.166 178.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 51.4 t -107.29 125.04 50.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.97 0.415 . . . . 0.0 111.118 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 58.3 ttm-85 . . . . . 0 C--N 1.331 -0.223 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.389 179.785 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 16.4 t . . . . . 0 N--CA 1.452 -0.345 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.5 -41.59 95.49 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 120.424 -0.893 . . . . 0.0 111.311 -178.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.64 -41.64 64.43 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.844 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -152.47 160.57 31.06 Favored Pre-proline 0 CA--C 1.519 -0.22 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -82.71 122.38 3.48 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 N-CA-C 107.139 -1.908 . . . . 0.0 107.139 174.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 21.1 t -139.17 122.08 16.63 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 119.596 -0.842 . . . . 0.0 112.015 -177.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -57.31 -47.3 81.86 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.743 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -168.1 128.51 1.33 Allowed 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.551 179.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 165.07 -168.37 39.18 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.6 t -95.69 117.28 30.2 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 48.9 t -98.43 107.68 20.2 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.206 -0.598 . . . . 0.0 110.677 -179.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 85.5 mtp180 -140.56 152.99 45.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.954 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 52.39 38.21 24.6 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.91 0.386 . . . . 0.0 110.469 179.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 58.31 26.67 14.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.661 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 91.2 mtm180 -139.99 146.24 38.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.514 179.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 54.1 t -101.52 120.71 40.73 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.559 -0.457 . . . . 0.0 110.662 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.231 -179.563 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 20.7 t . . . . . 0 N--CA 1.455 -0.209 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.62 -39.69 93.7 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 -179.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.44 -40.03 68.91 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.558 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -151.79 160.4 31.68 Favored Pre-proline 0 N--CA 1.464 0.273 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -179.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -84.3 123.02 2.94 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 106.798 -2.039 . . . . 0.0 106.798 174.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 13.7 t -133.69 124.57 26.94 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 119.503 -0.879 . . . . 0.0 111.369 -176.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -57.1 -50.88 71.41 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 119.633 -0.827 . . . . 0.0 109.685 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -168.77 131.49 1.35 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.286 179.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 157.72 -165.47 33.56 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 79.5 m -99.71 128.82 45.8 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 54.1 t -104.35 110.42 22.65 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.836 -0.345 . . . . 0.0 111.442 -179.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -142.48 152.39 42.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.308 179.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 50.01 42.66 24.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.545 179.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 47.8 t0 56.64 28.42 14.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.945 0.403 . . . . 0.0 111.198 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 91.9 mtm180 -140.54 146.88 38.67 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 54.0 t -120.39 124.42 45.47 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.674 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 58.0 ttm-85 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.172 179.804 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 13.1 t . . . . . 0 N--CA 1.45 -0.436 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.85 -41.89 96.33 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 120.437 -0.887 . . . . 0.0 111.363 -178.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.51 -42.51 63.72 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 120.858 -0.686 . . . . 0.0 111.952 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -152.63 161.71 28.46 Favored Pre-proline 0 N--CA 1.463 0.194 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -178.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -84.3 122.66 2.88 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.0 1.8 . . . . 0.0 108.387 175.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -128.73 120.9 27.3 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.373 0.606 . . . . 0.0 111.726 -178.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -59.14 -41.47 88.37 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.153 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -172.85 125.53 0.46 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.851 178.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 163.75 -166.83 37.58 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.834 -0.907 . . . . 0.0 110.834 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 85.8 m -101.97 131.8 48.16 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.8 t -117.08 120.96 39.96 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.705 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -141.94 139.42 32.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.127 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 54.33 46.15 25.72 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.028 -179.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 55.6 34.25 22.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.592 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 61.8 ttp180 -141.96 129.34 21.2 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 46.3 t -101.5 121.54 42.15 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.188 -179.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 58.7 ttm-85 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.367 179.937 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 21.6 t . . . . . 0 N--CA 1.452 -0.353 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.94 -40.41 93.2 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 120.048 -1.073 . . . . 0.0 110.879 -178.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.59 -40.93 66.37 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 120.851 -0.69 . . . . 0.0 111.715 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -152.13 159.42 32.92 Favored Pre-proline 0 N--CA 1.465 0.279 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -178.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -82.43 122.49 3.63 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 N-CA-C 106.94 -1.985 . . . . 0.0 106.94 174.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 27.1 t -136.32 122.24 20.05 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 119.793 -0.763 . . . . 0.0 112.13 -177.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -59.98 -41.78 92.76 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.57 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -173.86 133.22 0.44 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.788 0.328 . . . . 0.0 110.7 179.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 155.34 -165.75 32.46 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 70.7 m -98.89 128.67 45.14 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 44.8 t -102.91 108.65 19.93 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.625 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -139.94 151.08 45.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.972 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 50.64 40.91 25.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.751 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 55.19 33.61 20.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.807 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 44.4 ttm180 -146.87 135.2 21.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.071 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 53.2 t -99.32 121.91 41.74 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.279 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 . . . . . 0 C--N 1.332 -0.191 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.599 179.656 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.399 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.27 142.81 58.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.876 0.37 . . . . 0.0 110.928 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 79.0 mtm -63.0 -39.69 95.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.628 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.06 16.61 80.57 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.457 -0.657 . . . . 0.0 111.457 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 51.0 p-10 -83.49 176.77 8.81 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.047 0.451 . . . . 0.0 110.95 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.667 HG12 ' O ' ' A' ' 14' ' ' LYS . 8.9 p -139.82 159.04 27.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.686 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.435 ' N ' HG22 ' A' ' 6' ' ' VAL . 81.7 m-20 -137.44 147.26 45.21 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 21.6 t -108.15 141.59 39.64 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.02 -39.56 94.42 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -178.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.19 -39.72 71.86 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.62 157.78 40.9 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-O 121.063 0.458 . . . . 0.0 112.07 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -83.35 122.0 3.14 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 N-CA-C 108.262 -1.476 . . . . 0.0 108.262 175.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 19.7 t -149.71 111.59 4.57 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.667 ' O ' HG12 ' A' ' 6' ' ' VAL . 68.4 mttm -59.99 -40.05 87.82 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -178.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -156.68 133.25 10.08 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.954 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 148.39 -168.9 29.05 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 78.3 m -102.65 127.71 49.64 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.861 -0.335 . . . . 0.0 110.142 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 50.8 t -104.15 114.1 28.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.049 0.452 . . . . 0.0 110.894 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -138.9 146.83 41.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.274 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 49.63 41.37 21.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.751 0.31 . . . . 0.0 110.685 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 55.92 35.82 26.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.005 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 32.4 tpt180 -146.7 131.98 18.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.121 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 43.6 t -95.31 121.52 37.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.011 0.434 . . . . 0.0 110.716 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 58.6 ttm-85 -116.89 131.34 56.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.596 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -111.33 75.0 0.89 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 11.7 tt 169.64 149.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.555 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 55.44 37.97 29.63 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.296 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 41.9 t -148.68 131.53 16.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.877 0.37 . . . . 0.0 110.538 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 66.8 t0 . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 118.104 -0.951 . . . . 0.0 110.375 179.879 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.51 141.79 58.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.913 0.387 . . . . 0.0 110.572 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.3 mmt -130.19 149.8 51.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.624 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -77.02 170.66 55.16 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 47.5 p30 -157.24 176.14 13.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.899 0.381 . . . . 0.0 110.907 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.5 t -127.19 137.9 56.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.166 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -138.25 132.75 32.22 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.587 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.1 t -109.81 145.69 36.29 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.08 -40.31 95.44 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.699 -178.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.4 -39.89 69.42 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 120.93 -0.652 . . . . 0.0 111.474 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -152.42 156.88 33.76 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.563 0.22 . . . . 0.0 111.526 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -82.83 122.32 3.42 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 N-CA-C 107.882 -1.622 . . . . 0.0 107.882 175.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 18.0 t -141.89 116.01 9.39 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.977 -178.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 58.2 mtmt -61.6 -40.06 93.46 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.689 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -160.32 130.65 5.39 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.829 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 152.26 -172.2 31.5 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 69.1 m -99.39 129.01 45.55 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.7 t -104.16 110.51 22.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.123 0.487 . . . . 0.0 110.853 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -138.65 149.4 45.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.729 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 51.23 39.91 24.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.936 0.398 . . . . 0.0 110.324 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 56.72 30.02 16.85 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.299 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -139.09 144.95 38.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.078 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 47.6 t -105.38 121.21 43.43 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.635 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -109.84 133.04 53.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.837 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -122.86 74.7 1.22 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.0 tt 169.79 127.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 O-C-N 123.927 0.767 . . . . 0.0 110.498 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 50.72 38.88 20.54 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.914 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 43.4 t -61.49 -48.4 81.24 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.389 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.754 -179.889 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.25 152.51 37.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.822 0.344 . . . . 0.0 110.572 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 60.4 ttm -109.67 126.47 53.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.781 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -82.7 -179.67 52.8 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 51.6 p30 -155.95 175.78 13.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.951 0.405 . . . . 0.0 110.817 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 53.1 t -125.97 137.72 56.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.891 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -135.95 126.57 27.11 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.589 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 16.5 t -100.74 143.75 30.53 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.1 -40.48 93.64 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 120.808 -0.71 . . . . 0.0 111.59 -178.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.3 -41.28 68.76 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 120.454 -0.879 . . . . 0.0 111.417 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -149.1 159.42 37.21 Favored Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -84.23 122.26 2.84 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 N-CA-C 108.026 -1.567 . . . . 0.0 108.026 175.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 22.7 t -143.4 117.41 9.43 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.805 -178.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -60.29 -45.23 94.08 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.419 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -159.45 130.24 5.9 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.079 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 156.12 -166.94 33.23 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 83.2 m -102.02 127.13 49.03 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 47.2 t -102.86 110.45 22.38 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.693 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -138.61 148.87 44.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.0 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 50.09 40.98 22.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.92 0.39 . . . . 0.0 110.482 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 54.69 33.07 18.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.892 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 78.3 ttt-85 -143.0 134.08 25.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.962 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 45.5 t -97.34 120.79 38.35 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.803 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -109.1 134.56 51.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.45 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -119.42 74.99 1.03 Allowed 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.271 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.9 tt 171.42 142.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.422 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 52.77 37.51 24.08 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.7 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.5 t -145.97 130.72 18.02 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.517 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.546 179.972 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.388 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.94 -40.03 94.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.855 0.359 . . . . 0.0 110.694 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 79.0 mtm 53.97 40.66 31.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.57 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.47 177.95 53.97 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -108.57 137.7 46.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.803 0.335 . . . . 0.0 110.752 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 44.0 t -97.17 144.05 11.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.489 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -139.33 129.33 25.04 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 12.8 t -107.46 144.36 34.52 Favored 'General case' 0 C--O 1.231 0.1 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.04 -40.63 95.79 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 121.05 -0.595 . . . . 0.0 111.814 -178.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.04 -39.73 73.47 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.408 HG21 ' HA ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -150.41 156.15 36.82 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.852 0.358 . . . . 0.0 111.346 -179.544 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -83.69 122.28 3.06 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 N-CA-C 108.126 -1.529 . . . . 0.0 108.126 175.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 21.0 t -144.25 110.97 5.66 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 120.311 -0.556 . . . . 0.0 110.299 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -60.07 -40.34 89.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.95 -178.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 93.6 t80 -154.28 130.9 10.68 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.101 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 149.41 -171.0 29.62 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 79.5 m -101.66 130.46 48.02 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 49.9 t -104.8 111.58 24.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.099 0.476 . . . . 0.0 111.093 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -138.37 148.27 44.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.087 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 50.42 40.67 23.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.854 0.359 . . . . 0.0 110.48 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 56.76 30.67 18.08 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.171 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.408 ' HA ' HG21 ' A' ' 11' ' ' VAL . 99.7 mtt180 -139.47 147.07 40.83 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 42.6 t -108.47 124.08 49.87 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.445 -0.502 . . . . 0.0 111.09 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.487 ' HE ' HG23 ' A' ' 26' ' ' ILE . 71.9 ttt180 -121.44 136.4 54.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.582 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -121.31 75.0 1.14 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.66 -0.416 . . . . 0.0 109.999 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.487 HG23 ' HE ' ' A' ' 24' ' ' ARG . 5.3 tt 169.75 140.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.192 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 49.8 t0 51.63 41.98 29.27 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.233 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 53.7 t -99.57 119.41 38.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.795 0.331 . . . . 0.0 110.351 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 65.6 t0 . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.504 -179.82 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.381 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.51 153.96 36.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.864 0.364 . . . . 0.0 110.571 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 79.5 mtm -131.47 146.27 52.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.477 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -177.13 -178.32 46.74 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 52.8 p30 -155.56 177.72 11.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.74 0.305 . . . . 0.0 110.601 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 46.3 t -102.29 144.3 13.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.382 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -138.98 127.16 22.61 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 10.5 t -107.12 143.34 35.42 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.05 -39.41 94.28 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.618 -178.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.26 -39.73 71.09 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.93 152.44 31.7 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 120.724 0.297 . . . . 0.0 111.471 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -81.04 122.19 4.19 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 N-CA-C 107.692 -1.695 . . . . 0.0 107.692 175.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 18.4 t -142.75 111.27 6.21 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.623 -177.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -57.36 -45.63 84.18 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.642 -178.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 93.6 t80 -152.86 130.37 11.44 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.822 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 154.48 -171.44 32.95 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.7 m -102.48 126.73 49.62 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 50.5 t -104.03 118.21 36.12 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.995 -179.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -152.92 144.67 23.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.643 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 57.07 37.57 28.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.855 0.36 . . . . 0.0 110.299 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 57.85 29.67 17.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.468 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -137.56 149.44 46.71 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 52.1 t -117.22 126.11 52.23 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.132 0.491 . . . . 0.0 110.844 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -117.82 136.38 53.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.431 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -122.58 75.17 1.24 Allowed 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.04 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.0 tt 171.25 141.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.082 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 53.54 35.19 20.2 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.546 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 41.9 t -141.32 130.11 22.96 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.508 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 . . . . . 0 C--O 1.221 -0.447 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.749 -179.899 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.346 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.25 143.25 58.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.84 0.352 . . . . 0.0 110.588 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.9 ptp -153.91 161.35 42.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.575 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -177.55 179.54 48.16 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 51.3 p30 -155.61 177.04 11.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.798 0.332 . . . . 0.0 111.003 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.423 ' O ' ' O ' ' A' ' 13' ' ' CYS . 46.9 t -127.48 139.86 50.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -114.23 108.57 17.13 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.892 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.9 t -89.88 149.44 22.64 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.51 -41.65 95.54 Favored Glycine 0 CA--C 1.523 0.535 0 C-N-CA 120.347 -0.93 . . . . 0.0 111.299 -178.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.57 -41.63 65.1 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 120.766 -0.73 . . . . 0.0 111.968 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -152.37 158.71 33.41 Favored Pre-proline 0 N--CA 1.464 0.226 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -178.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -81.81 122.65 3.96 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 N-CA-C 106.815 -2.033 . . . . 0.0 106.815 174.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.423 ' O ' ' O ' ' A' ' 6' ' ' VAL . 26.0 t -135.33 121.03 19.53 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 119.748 -0.781 . . . . 0.0 112.216 -177.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -59.43 -41.45 89.62 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.838 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 93.5 t80 -173.04 131.17 0.49 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.718 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 157.93 -166.01 33.85 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 71.8 m -99.62 127.75 45.72 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 48.9 t -104.05 110.19 22.26 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.454 -0.499 . . . . 0.0 110.667 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -139.32 151.35 46.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.799 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 51.84 39.16 25.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.886 0.374 . . . . 0.0 110.368 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 57.37 29.22 16.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.09 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -139.19 148.05 42.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.357 -0.383 . . . . 0.0 109.97 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 52.3 t -111.8 125.6 54.18 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.205 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -117.13 131.52 56.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.433 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -122.77 75.25 1.26 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.417 HG23 ' O ' ' A' ' 26' ' ' ILE . 11.5 tt 171.54 127.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.156 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 51.02 36.61 15.65 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.365 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 44.4 t -61.4 -47.8 84.15 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.324 -0.551 . . . . 0.0 110.632 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 117.961 -1.018 . . . . 0.0 110.538 179.876 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.26 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.83 142.0 58.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.859 0.362 . . . . 0.0 110.509 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 95.9 mmm -62.57 -39.64 94.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.465 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.69 -173.02 52.44 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 52.5 p30 -154.51 175.04 14.09 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.778 0.323 . . . . 0.0 110.701 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.7 t -102.8 146.1 11.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.194 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -139.05 126.81 22.05 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.8 t -105.04 145.87 29.88 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.46 -40.4 96.12 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.669 -178.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.46 -40.03 68.64 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.319 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.94 154.67 34.65 Favored Pre-proline 0 C--N 1.329 -0.303 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -179.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -81.42 122.39 4.07 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 N-CA-C 107.955 -1.594 . . . . 0.0 107.955 175.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 18.1 t -143.2 111.97 6.47 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.313 -178.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -58.0 -45.84 86.19 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.491 -178.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -153.05 129.83 10.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.816 0.341 . . . . 0.0 110.718 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 154.08 -172.68 32.72 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.7 m -100.31 128.2 46.43 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 49.9 t -103.33 111.49 23.93 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.967 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -139.54 147.64 41.5 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.12 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 49.8 43.28 24.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.893 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 53.52 34.92 19.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.792 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -145.17 134.1 22.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.868 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 45.9 t -99.08 123.86 43.68 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.193 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -105.74 140.66 38.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.744 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -122.25 117.68 26.72 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.3 tp 85.08 155.26 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 O-C-N 125.122 1.514 . . . . 0.0 109.89 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 51.5 t0 59.49 43.44 16.19 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -178.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 49.9 t -116.64 124.3 49.43 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.534 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 . . . . . 0 C--O 1.221 -0.435 0 CA-C-O 117.922 -1.037 . . . . 0.0 110.392 179.829 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.61 144.14 57.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.729 0.299 . . . . 0.0 110.466 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.4 ptt? -154.12 160.89 42.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.465 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -177.34 179.21 48.2 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 53.1 p30 -155.01 171.13 20.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.109 0.48 . . . . 0.0 110.996 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.626 HG12 ' O ' ' A' ' 14' ' ' LYS . 9.1 p -138.91 159.56 30.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.324 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.435 ' N ' HG22 ' A' ' 6' ' ' VAL . 52.2 p30 -139.7 157.31 45.97 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.437 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 16.2 t -117.69 140.44 49.66 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.46 -39.37 94.8 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.24 -40.05 71.07 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.11 157.12 46.62 Favored Pre-proline 0 C--N 1.331 -0.223 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -179.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -83.26 122.26 3.23 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 N-CA-C 108.215 -1.494 . . . . 0.0 108.215 176.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 24.1 t -151.36 110.99 4.01 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 120.589 -0.445 . . . . 0.0 110.159 -178.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.626 ' O ' HG12 ' A' ' 6' ' ' VAL . 98.2 mttt -60.67 -40.45 92.16 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 111.779 0.288 . . . . 0.0 111.779 -179.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 94.7 t80 -154.02 134.19 13.28 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.058 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 147.49 -170.58 28.24 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 86.5 m -102.05 129.31 48.33 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 47.1 t -103.82 111.7 24.34 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.026 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -140.75 148.7 41.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.582 179.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 50.94 40.56 25.47 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.927 0.394 . . . . 0.0 110.862 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 58.68 25.04 12.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.063 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 91.8 mtm180 -138.64 144.81 39.86 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.218 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 45.7 t -103.39 123.19 46.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.955 0.407 . . . . 0.0 111.126 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 65.2 ttt180 -119.56 134.92 55.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.143 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -121.58 75.22 1.17 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.128 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 12.5 tt 171.47 139.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.796 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 53.2 t0 52.47 42.14 31.13 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.993 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 51.9 t -108.22 123.31 48.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.765 0.317 . . . . 0.0 110.527 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 67.1 t0 . . . . . 0 C--O 1.219 -0.539 0 CA-C-O 117.931 -1.033 . . . . 0.0 110.186 179.793 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.334 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.73 151.73 30.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.73 0.3 . . . . 0.0 110.389 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 64.1 mtt -131.5 150.32 52.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.742 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -72.61 159.4 53.63 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -70.48 140.69 51.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.879 0.371 . . . . 0.0 110.536 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 54.7 t -76.28 146.3 9.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.404 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -139.62 136.34 34.25 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.387 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 48.8 t -113.58 146.75 39.22 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.23 -40.98 94.61 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.21 -177.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.38 -41.39 67.69 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 120.47 -0.871 . . . . 0.0 111.652 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -152.72 163.01 24.88 Favored Pre-proline 0 CA--C 1.515 -0.369 0 CA-C-O 120.956 0.408 . . . . 0.0 111.696 -179.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -84.24 122.24 2.83 Favored 'Trans proline' 0 C--N 1.301 -1.928 0 C-N-CA 121.326 1.351 . . . . 0.0 109.191 176.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -133.5 111.32 10.61 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.98 -179.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -57.89 -40.88 81.36 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.34 -178.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 93.4 t80 -148.08 119.4 7.83 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.741 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 168.78 -170.5 42.38 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.429 -1.069 . . . . 0.0 110.429 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.9 m -105.5 127.73 53.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.972 0.415 . . . . 0.0 110.903 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 44.7 t -104.75 114.52 28.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.989 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.2 tpt180 -146.74 137.35 23.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.325 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 51.75 41.81 29.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.637 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 57.48 39.25 28.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.239 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -139.14 144.33 38.6 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.512 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 17.2 t -108.05 124.88 50.86 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.887 0.375 . . . . 0.0 110.615 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.401 ' HG2' HG22 ' A' ' 26' ' ' ILE . 60.3 ttt180 -115.2 134.45 55.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.633 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -118.21 74.93 0.98 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.33 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.401 HG22 ' HG2' ' A' ' 24' ' ' ARG . 18.0 tt 177.03 138.29 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.443 178.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 53.32 30.35 10.05 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.078 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 39.2 t -121.28 127.4 51.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.829 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 . . . . . 0 C--O 1.22 -0.471 0 CA-C-O 117.845 -1.074 . . . . 0.0 110.114 179.742 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.338 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.424 ' HB3' ' HB3' ' A' ' 5' ' ' ASN . . . -67.15 142.74 56.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.002 0.429 . . . . 0.0 110.764 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 60.5 ttm -69.68 130.26 41.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.324 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 81.7 5.16 90.07 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.161 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.424 ' HB3' ' HB3' ' A' ' 2' ' ' ALA . 45.1 p-10 -77.88 164.08 25.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 117.318 0.559 . . . . 0.0 110.596 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.4 p -158.52 124.44 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.403 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.187 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -86.99 138.8 31.2 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.696 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 31.3 t -91.98 143.23 26.69 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.258 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.92 -40.73 95.68 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -179.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.49 -40.43 67.92 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 121.011 -0.614 . . . . 0.0 111.696 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.7 152.99 60.96 Favored Pre-proline 0 N--CA 1.464 0.267 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -179.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -81.84 122.54 3.92 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 N-CA-C 108.004 -1.575 . . . . 0.0 108.004 175.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 44.5 t -146.69 130.32 16.93 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.57 -177.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 58.4 mtmt -63.23 -42.24 99.21 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.233 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -173.25 134.29 0.53 Allowed 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.937 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 156.73 -166.26 33.32 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.939 -0.865 . . . . 0.0 110.939 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 78.9 m -94.8 130.61 41.29 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 41.9 t -106.21 116.33 31.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.008 0.432 . . . . 0.0 110.828 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.1 tpt180 -145.46 139.36 26.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.324 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 52.86 43.85 31.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.279 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 56.79 33.02 22.33 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.304 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -138.41 147.54 43.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.003 179.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 43.2 t -119.37 127.45 53.16 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.995 0.426 . . . . 0.0 111.098 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 69.0 ttt180 -128.91 136.31 50.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.178 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -123.96 75.09 1.33 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.9 tt 169.01 132.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.721 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 56.14 27.07 10.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.322 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 45.8 t -61.84 -48.06 82.28 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.79 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 . . . . . 0 C--O 1.22 -0.5 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.646 -179.828 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.04 142.72 58.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.766 0.317 . . . . 0.0 110.574 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 28.0 ttt -111.71 127.55 55.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.709 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.12 177.65 54.25 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 52.4 p30 -155.4 177.34 11.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.888 0.375 . . . . 0.0 110.989 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.434 ' O ' ' O ' ' A' ' 13' ' ' CYS . 46.8 t -126.89 139.15 52.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.64 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -113.64 108.25 16.88 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 119.88 -0.728 . . . . 0.0 110.973 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 21.4 t -88.86 149.58 23.3 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.56 -41.65 95.64 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.373 -0.918 . . . . 0.0 111.064 -178.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.66 -41.46 64.57 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.976 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -152.39 159.42 32.71 Favored Pre-proline 0 N--CA 1.464 0.233 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -178.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -82.0 122.5 3.83 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 N-CA-C 107.071 -1.934 . . . . 0.0 107.071 174.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.434 ' O ' ' O ' ' A' ' 6' ' ' VAL . 24.8 t -135.06 121.42 20.35 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 119.82 -0.752 . . . . 0.0 112.087 -177.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -59.68 -41.88 91.68 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.85 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -172.67 131.4 0.55 Allowed 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.943 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 156.68 -166.67 33.43 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 84.6 m -99.24 128.66 45.39 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 44.1 t -104.67 109.76 21.82 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.624 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -139.18 150.69 45.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.153 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 51.09 40.39 25.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.966 0.412 . . . . 0.0 110.376 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 55.06 36.11 26.21 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.713 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 43.8 ttm180 -147.14 134.41 20.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.146 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 53.1 t -100.45 123.0 44.09 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.397 -0.521 . . . . 0.0 111.029 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.427 ' NE ' HG23 ' A' ' 26' ' ' ILE . 70.5 ttt180 -121.86 135.74 54.91 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.27 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -120.19 75.19 1.08 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.038 179.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.427 HG23 ' NE ' ' A' ' 24' ' ' ARG . 5.6 tt 170.81 139.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.461 0.112 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.134 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 53.37 38.35 27.65 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.207 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 48.4 t -100.06 120.82 40.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.865 0.364 . . . . 0.0 110.402 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.643 179.978 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.29 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.42 143.46 57.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.764 0.316 . . . . 0.0 110.537 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 28.3 ptm -152.79 160.22 43.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.756 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -179.98 -176.73 47.6 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 51.8 p30 -155.69 174.36 15.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.771 0.32 . . . . 0.0 111.064 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.4 t -128.28 136.73 59.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.502 0.668 . . . . 0.0 110.183 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -105.75 98.03 7.77 Favored 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.183 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 22.2 t -81.44 149.84 28.6 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.56 -41.19 95.4 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 120.178 -1.01 . . . . 0.0 110.993 -178.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.64 -42.78 62.0 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.042 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -152.56 159.61 32.33 Favored Pre-proline 0 N--CA 1.463 0.211 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -178.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -81.77 122.73 3.99 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 N-CA-C 106.805 -2.036 . . . . 0.0 106.805 174.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 29.8 t -136.68 124.03 21.98 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 119.878 -0.729 . . . . 0.0 111.68 -176.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -58.27 -47.64 82.95 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.6 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -170.23 131.92 1.01 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.691 179.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 158.97 -164.69 33.87 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 69.8 m -97.84 127.85 44.07 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 49.3 t -104.96 108.01 19.29 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.467 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -140.73 153.1 45.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.181 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 52.13 39.38 26.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.879 0.371 . . . . 0.0 110.584 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 57.99 25.34 12.13 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.667 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 92.1 mtm180 -139.56 147.14 40.77 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 47.8 t -106.82 125.57 51.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.041 0.448 . . . . 0.0 111.036 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -116.33 135.0 54.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.408 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -121.55 75.33 1.18 Allowed 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.673 -0.411 . . . . 0.0 109.921 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.3 tt 171.24 140.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.348 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 48.4 t0 52.75 40.04 29.74 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.571 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.4 t -142.69 129.66 20.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.738 0.304 . . . . 0.0 110.518 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 . . . . . 0 C--O 1.219 -0.544 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.585 -179.858 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.31 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.85 152.15 35.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.812 0.339 . . . . 0.0 110.701 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 99.6 mtp -129.21 147.19 51.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.772 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -176.55 179.4 47.59 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 52.2 p30 -156.41 176.45 12.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.925 0.393 . . . . 0.0 110.894 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.428 ' O ' ' O ' ' A' ' 13' ' ' CYS . 48.1 t -128.27 139.83 50.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.699 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -114.56 106.19 13.97 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.834 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.0 t -86.93 148.11 25.48 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.43 -40.96 94.98 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.844 -0.903 . . . . 0.0 110.844 -178.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.45 -41.7 66.22 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.919 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -152.54 158.01 33.42 Favored Pre-proline 0 N--CA 1.465 0.305 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -178.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -81.53 122.64 4.09 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 N-CA-C 106.944 -1.983 . . . . 0.0 106.944 174.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.428 ' O ' ' O ' ' A' ' 6' ' ' VAL . 23.5 t -136.15 120.66 18.18 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 119.901 -0.719 . . . . 0.0 112.268 -176.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -57.72 -47.24 82.97 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.481 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 94.5 t80 -168.76 129.89 1.22 Allowed 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.825 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 157.73 -168.22 34.32 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 77.5 m -96.59 129.53 43.96 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 47.2 t -103.58 115.45 30.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.906 0.384 . . . . 0.0 110.611 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 19.4 tpt180 -155.81 150.52 26.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.945 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 57.4 37.66 28.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.064 0.459 . . . . 0.0 110.446 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 56.71 26.25 11.09 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.211 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -139.78 150.23 44.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.314 -0.403 . . . . 0.0 109.927 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 53.9 t -118.5 126.66 52.49 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.853 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 58.4 ttm-85 -125.35 131.26 53.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.45 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -110.86 75.05 0.9 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.2 tt 169.89 148.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.578 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 55.77 37.45 28.88 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 121.004 -0.278 . . . . 0.0 110.925 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 44.1 t -144.67 130.48 19.19 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.321 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 67.5 t0 . . . . . 0 C--O 1.219 -0.54 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.215 -179.864 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.292 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.53 141.98 58.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.79 0.329 . . . . 0.0 110.556 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 98.5 mtp -62.98 -39.95 96.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.453 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.21 1.45 90.38 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 121.271 -0.49 . . . . 0.0 111.996 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -72.74 143.21 48.07 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.799 0.333 . . . . 0.0 110.771 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.442 ' O ' ' O ' ' A' ' 13' ' ' CYS . 60.8 t -115.81 141.57 32.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.184 0.516 . . . . 0.0 110.678 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -121.8 107.26 12.1 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.777 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 52.5 t -88.82 148.05 24.1 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.65 -40.56 92.81 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 120.621 -0.8 . . . . 0.0 111.549 -178.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.49 -43.88 60.03 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 120.43 -0.89 . . . . 0.0 111.527 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -152.76 165.03 18.46 Favored Pre-proline 0 N--CA 1.466 0.341 0 CA-C-O 121.025 0.44 . . . . 0.0 111.862 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -83.38 122.38 3.2 Favored 'Trans proline' 0 C--N 1.302 -1.901 0 C-N-CA 121.554 1.503 . . . . 0.0 108.974 176.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.442 ' O ' ' O ' ' A' ' 6' ' ' VAL . 8.8 t -115.78 113.08 22.95 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.185 -178.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -53.5 -50.01 66.3 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 119.681 -0.807 . . . . 0.0 110.157 -179.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 93.4 t80 -170.94 100.48 0.22 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.313 -0.403 . . . . 0.0 109.926 178.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -178.57 -161.34 26.24 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 64.7 m -101.13 133.96 44.87 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 50.0 t -102.12 111.29 23.52 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.575 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -138.99 146.93 41.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.343 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 47.32 43.98 15.66 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.154 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 50.9 t0 54.51 41.58 31.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.953 0.406 . . . . 0.0 110.289 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 78.1 ttt-85 -145.27 133.35 21.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.879 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -93.74 111.83 23.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.274 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -106.99 130.88 54.57 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.142 -179.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -122.63 75.02 1.23 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.587 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 19.1 tt 178.85 140.15 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.576 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 36.9 t0 48.86 25.76 1.13 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.929 179.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 40.0 t -149.39 132.5 16.31 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.712 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 117.86 -1.067 . . . . 0.0 110.581 179.87 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.231 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 55.64 39.05 30.89 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.892 0.377 . . . . 0.0 110.613 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 60.8 ttm -106.48 127.06 53.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.31 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -177.83 -179.21 47.86 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 50.0 p30 -155.61 177.2 11.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.902 0.382 . . . . 0.0 111.024 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 53.6 t -103.13 144.97 13.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.387 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -139.15 125.39 20.18 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 12.8 t -104.75 143.31 33.28 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.64 -39.39 93.34 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.51 -0.636 . . . . 0.0 111.51 -178.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.23 -39.67 71.44 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.86 155.62 33.84 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.817 0.341 . . . . 0.0 111.421 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -82.77 122.37 3.45 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 N-CA-C 107.895 -1.617 . . . . 0.0 107.895 175.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 19.7 t -143.46 112.42 6.63 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.544 -178.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -57.75 -44.9 86.42 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.54 -178.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -153.3 132.81 12.93 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.908 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 150.97 -169.93 30.71 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 78.3 m -102.36 130.13 49.01 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.7 t -105.45 111.79 24.64 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.426 -0.509 . . . . 0.0 111.178 -179.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -140.13 149.02 42.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.821 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 51.48 38.55 22.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.962 0.411 . . . . 0.0 110.335 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 57.5 30.43 18.68 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.221 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 86.0 mtp180 -138.46 147.31 43.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.242 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 42.9 t -106.7 123.1 47.63 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.201 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 66.1 ttt180 -121.47 136.09 54.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.309 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -123.21 74.97 1.27 Allowed 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.749 -0.381 . . . . 0.0 110.326 178.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.5 tt 173.27 140.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.946 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 55.36 35.76 25.65 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.283 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 53.1 t -120.14 127.3 52.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.29 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 68.3 t0 . . . . . 0 C--O 1.22 -0.46 0 CA-C-O 118.003 -0.998 . . . . 0.0 110.25 179.811 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.29 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.47 142.18 58.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.779 0.323 . . . . 0.0 110.754 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 66.4 mtt -129.77 148.05 51.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.454 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -178.88 179.22 48.89 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 52.4 p30 -154.61 170.29 21.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.815 0.34 . . . . 0.0 110.965 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 33.3 m -133.57 157.65 42.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.241 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -121.06 103.05 8.73 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.569 -0.453 . . . . 0.0 110.928 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.7 t -77.83 147.28 35.26 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 178.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.94 -40.57 93.42 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 120.112 -1.042 . . . . 0.0 110.537 -178.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.59 -41.4 65.41 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.119 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -152.16 160.59 31.19 Favored Pre-proline 0 N--CA 1.466 0.337 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -178.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -82.42 122.64 3.67 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 N-CA-C 106.802 -2.038 . . . . 0.0 106.802 174.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 33.2 t -136.99 125.25 23.19 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 119.796 -0.762 . . . . 0.0 111.946 -176.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -59.11 -46.82 87.32 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.39 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -173.03 132.89 0.52 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.605 179.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 156.79 -164.39 32.65 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 84.6 m -98.54 129.94 45.1 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.1 t -106.07 109.51 21.48 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.732 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 68.1 mtp85 -140.66 153.1 45.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.093 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 52.38 38.75 25.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.987 0.422 . . . . 0.0 110.667 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 58.12 25.42 12.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.588 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 91.5 mtm180 -139.56 145.82 39.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.166 178.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 51.4 t -107.29 125.04 50.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.97 0.415 . . . . 0.0 111.118 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 58.3 ttm-85 -121.06 130.32 53.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.389 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -111.86 75.17 0.9 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 178.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.6 tt 169.44 148.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.474 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 50.2 t0 54.78 42.19 31.35 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.123 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 44.5 t -144.74 130.3 18.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.921 0.391 . . . . 0.0 110.531 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 . . . . . 0 C--O 1.221 -0.437 0 CA-C-O 118.077 -0.963 . . . . 0.0 110.516 -179.764 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.35 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.05 154.61 39.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.826 0.346 . . . . 0.0 110.461 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 67.1 ttp -112.74 128.76 56.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.699 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -177.06 179.54 47.92 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 50.8 p30 -156.59 174.35 15.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.865 0.364 . . . . 0.0 111.008 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.423 ' O ' ' O ' ' A' ' 13' ' ' CYS . 49.3 t -128.96 140.34 49.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.652 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -110.99 104.86 13.48 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.794 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 16.4 t -84.98 149.36 25.66 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.5 -41.59 95.49 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 120.424 -0.893 . . . . 0.0 111.311 -178.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.64 -41.64 64.43 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.844 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -152.47 160.57 31.06 Favored Pre-proline 0 CA--C 1.519 -0.22 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -82.71 122.38 3.48 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 N-CA-C 107.139 -1.908 . . . . 0.0 107.139 174.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.423 ' O ' ' O ' ' A' ' 6' ' ' VAL . 21.1 t -139.17 122.08 16.63 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 119.596 -0.842 . . . . 0.0 112.015 -177.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -57.31 -47.3 81.86 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.743 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -168.1 128.51 1.33 Allowed 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.551 179.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 165.07 -168.37 39.18 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.6 t -95.69 117.28 30.2 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 48.9 t -98.43 107.68 20.2 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.206 -0.598 . . . . 0.0 110.677 -179.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 85.5 mtp180 -140.56 152.99 45.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.954 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 52.39 38.21 24.6 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.91 0.386 . . . . 0.0 110.469 179.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 58.31 26.67 14.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.661 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 91.2 mtm180 -139.99 146.24 38.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.514 179.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 54.1 t -101.52 120.71 40.73 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.559 -0.457 . . . . 0.0 110.662 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.46 ' HG2' HG22 ' A' ' 26' ' ' ILE . 68.1 ttt180 -131.26 138.75 49.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.231 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -112.41 75.15 0.9 Allowed 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.511 -0.476 . . . . 0.0 109.949 179.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.46 HG22 ' HG2' ' A' ' 24' ' ' ARG . 6.9 tt 171.09 147.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.136 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 59.17 18.48 6.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.741 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.1 t -143.72 130.84 20.66 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.241 179.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 118.018 -0.991 . . . . 0.0 110.444 -179.772 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 108.742 -1.743 . . . . 0.0 108.742 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.81 -38.58 85.9 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -143.25 170.84 15.01 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.088 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 84.25 1.84 89.38 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 111.74 -0.544 . . . . 0.0 111.74 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -110.67 131.03 55.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.83 0.315 . . . . 0.0 110.37 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 34.5 m -126.47 158.06 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 120.233 -0.587 . . . . 0.0 111.145 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -125.26 101.18 6.86 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.123 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 20.7 t -77.58 145.0 37.1 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.62 -39.69 93.7 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 -179.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.44 -40.03 68.91 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.558 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -151.79 160.4 31.68 Favored Pre-proline 0 N--CA 1.464 0.273 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -179.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -84.3 123.02 2.94 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 106.798 -2.039 . . . . 0.0 106.798 174.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 13.7 t -133.69 124.57 26.94 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 119.503 -0.879 . . . . 0.0 111.369 -176.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -57.1 -50.88 71.41 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 119.633 -0.827 . . . . 0.0 109.685 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -168.77 131.49 1.35 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.286 179.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 157.72 -165.47 33.56 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 79.5 m -99.71 128.82 45.8 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 54.1 t -104.35 110.42 22.65 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.836 -0.345 . . . . 0.0 111.442 -179.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -142.48 152.39 42.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.308 179.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 50.01 42.66 24.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.545 179.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 47.8 t0 56.64 28.42 14.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.945 0.403 . . . . 0.0 111.198 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 91.9 mtm180 -140.54 146.88 38.67 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 54.0 t -120.39 124.42 45.47 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.674 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 58.0 ttm-85 -120.65 131.17 54.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.172 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -109.82 75.06 0.92 Allowed 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 120.237 -0.585 . . . . 0.0 109.554 179.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.1 tt 170.12 148.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.057 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 56.06 35.22 25.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.168 179.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.4 t -145.74 129.13 16.87 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.98 0.419 . . . . 0.0 110.812 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 118.105 -0.95 . . . . 0.0 110.914 179.932 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.86 -41.3 97.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.966 0.412 . . . . 0.0 110.47 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 78.4 mtm -63.2 -39.66 95.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.71 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -74.49 168.63 54.47 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.044 -0.823 . . . . 0.0 111.044 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 52.4 p30 -156.76 178.17 10.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.779 0.323 . . . . 0.0 110.634 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.423 ' O ' ' O ' ' A' ' 13' ' ' CYS . 47.7 t -125.21 138.58 53.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -117.25 108.68 15.94 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 120.029 -0.669 . . . . 0.0 110.923 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 13.1 t -89.28 150.31 22.67 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.85 -41.89 96.33 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 120.437 -0.887 . . . . 0.0 111.363 -178.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.51 -42.51 63.72 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 120.858 -0.686 . . . . 0.0 111.952 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -152.63 161.71 28.46 Favored Pre-proline 0 N--CA 1.463 0.194 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -178.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -84.3 122.66 2.88 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.0 1.8 . . . . 0.0 108.387 175.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.423 ' O ' ' O ' ' A' ' 6' ' ' VAL . 0.5 OUTLIER -128.73 120.9 27.3 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.373 0.606 . . . . 0.0 111.726 -178.182 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -59.14 -41.47 88.37 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.153 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -172.85 125.53 0.46 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.851 178.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 163.75 -166.83 37.58 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.834 -0.907 . . . . 0.0 110.834 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 85.8 m -101.97 131.8 48.16 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.8 t -117.08 120.96 39.96 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.705 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -141.94 139.42 32.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.127 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 54.33 46.15 25.72 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.028 -179.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 55.6 34.25 22.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.592 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 61.8 ttp180 -141.96 129.34 21.2 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 46.3 t -101.5 121.54 42.15 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.188 -179.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 58.7 ttm-85 -118.44 131.11 56.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.367 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -112.66 74.84 0.88 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.5 tt 169.26 148.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.733 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 50.0 t0 55.41 41.59 30.87 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.227 179.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 50.1 t -144.94 130.19 18.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.35 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 . . . . . 0 C--O 1.221 -0.402 0 CA-C-O 118.039 -0.981 . . . . 0.0 110.581 -179.865 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.338 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.93 142.48 58.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.742 0.306 . . . . 0.0 110.649 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 60.6 ttm -109.59 127.87 54.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.518 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 179.98 -178.72 48.67 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 50.5 p30 -156.01 177.45 11.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.92 0.39 . . . . 0.0 110.993 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.2 t -127.5 140.13 49.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.848 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -116.14 97.73 6.23 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 119.996 -0.682 . . . . 0.0 110.798 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 21.6 t -77.76 146.02 36.12 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.94 -40.41 93.2 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 120.048 -1.073 . . . . 0.0 110.879 -178.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.59 -40.93 66.37 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 120.851 -0.69 . . . . 0.0 111.715 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -152.13 159.42 32.92 Favored Pre-proline 0 N--CA 1.465 0.279 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -178.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -82.43 122.49 3.63 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 N-CA-C 106.94 -1.985 . . . . 0.0 106.94 174.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 27.1 t -136.32 122.24 20.05 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 119.793 -0.763 . . . . 0.0 112.13 -177.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -59.98 -41.78 92.76 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.57 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -173.86 133.22 0.44 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.788 0.328 . . . . 0.0 110.7 179.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 155.34 -165.75 32.46 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 70.7 m -98.89 128.67 45.14 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 44.8 t -102.91 108.65 19.93 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.625 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -139.94 151.08 45.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.972 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 50.64 40.91 25.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.751 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 55.19 33.61 20.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.807 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 44.4 ttm180 -146.87 135.2 21.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.071 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 53.2 t -99.32 121.91 41.74 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.279 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.41 ' HE ' HG23 ' A' ' 26' ' ' ILE . 67.6 ttt180 -111.81 135.08 52.9 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.599 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -121.16 75.33 1.15 Allowed 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.003 179.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.41 HG23 ' HE ' ' A' ' 24' ' ' ARG . 6.8 tt 171.17 140.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.383 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 39.1 t0 52.95 39.89 30.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.552 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.0 t -142.14 130.63 22.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.763 0.316 . . . . 0.0 110.586 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 54.7 p30 . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 118.073 -0.965 . . . . 0.0 110.604 -179.993 . . . . . . . . 0 0 . 1 stop_ save_